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ABSTRACT
Effects of Gold Compoundson Rat Behavior
by
Jonas Kaye, Doctor of Philosophy
Utah State University,

1969

Major Professor: Heber C, Sharp
Department: Psychology
Seven rats were trained on Fixed Rati o 20 and two on Fixed Ratio
12 Escape Schedules until a stable baseline was established.
of the subjects were administered gold thioglucose,

Five

three received

gold thiomalate, and one was injected with gold, gold thioglucose,
gold thiomal ate, allowing for an i ntrasubject

and

comparison. Colloidal

gold appeared to suppress response rate for one or two sessions, while
gold thioglucose and gold thiomalate suppressed normal response rates
from several to a number of sessions .

This response rate suppression

was often followed by gradual recovery, although in several subjects
recovery of response rate could not be achieved prior to termination
of the experiments ,
The drop i n response rate was more consistent for the gold thiomalatetreated subjects than for the gold thioglucose group.

A toxic effect

of the injected compoundswas manifest as a loss of weight, which was
regularly associated with a drop in response rate . This weight reduction was greatest in the gold thiomalate - injected animals, indicating
that gold thiomalate is probably more toxic than gold thioglucose to rats.
Tolerance was developed for gold th i oglucose and gold thiomalate,
as indicated by smaller response rate decrements after repeated

ix
injections
istrations,

of the compound
. As a consequence of repeated drug adminthe animals demonstrated that they could tolerate

a 1

milligram per gram of body weight dose of gold thioglucose if the
dosage was increased gradual l y f r om a low-dosage initial

injection .

This dosage of 1 milligram per gram of body weight is double the
amount required to produce demonstrable hypothalamic lesions in the rat . 1
Previous investigations
tolerance in rats,

have failed to demonstrate this degree of

primari ly because the ani mals did not have the

opportunity to adapt themselves to this treatment.
Decrease in spontaneous activity

on a balance beam apparatus was

observed in several rats following administration

of the larger gold

thioglucose dosages (i . e. , 0, 5 mil l i grams per gram of body weight to
1. 0 mi lligram per gram of body weight), as well as following the
admi ni stration

of gol d th i omal ate ,

Dosages of 20 mi lligrams to 50 milligrams of gold chloride were
lethal to two rats ,
The heavy dosage of gold th i ogl ucose administered to the female
rat subj ects at Utah State Univers i ty (i . e , , up to 1 mg per gram of
body wei ght), although potent i ally producing extensive hypothalamic
les i ons, 2 did not produce demonstrable hyperphagia or obesity, probably
due to the anorexia and hypophagi a associated with liver and kidney
damage,3 which could counteract the hyperphagia expected to be associated
1J. W. Wagner and J. DeGroot, "Effect of Gold Thioglucose Injections
on Survival, Organ Damageand Obesity in the Rat, Soc. Exp. BioZ. and
Med. , CXII (1963), 33-37.
11

2I bid .

3w. D. Block, 0. H, Buchanan, and R. H. Freyberg, "Metabolism,
Toxicity, and Manner of Action of Gold Compoundsused in the Treatment of
Arthritis," J. of Pharmac , and ExptZ . Therap., LXXVI(1942), 355-357.

X

with the extensive hypothalamic lesions produced at dosages over 0. 5
milligram per gram of body weight following gold thioglucose admin,. s t ra t ,· on. 4

( 111 pages)

4wagner and DeGroot, op. cit.

INTRODUCTION
Gold, gold thioglucose,
currently utilized

and gold thiomalate are drugs which are

in medical practice in the diagnosis and treatment

of cancer and rheumatoid arthritis

(Drill,

would not have received much attention

1954),

Yet, these compounds

from behavioral pharmacologists

within the larger sphere of psychology, had not Brecher and Waxler
(1949) discovered, following a single massive dose of gold thioglucose
into a mouse, that within weeks the animals practically

doubled its

size from overeating (hyperphagia) , The problem, which became obvious
in time, was an apparent discrepancy between the obesity and hypothalamic lesions (Marshall, Barnett, and Mayer, 1955) produced following
a gold thioglucose injection

and a lack of obesity and overt symptoms

in humans receiving this drug during arthritic
The purpose of this investigation
effects

therapy.

was to evaluate the apparent

that gold-containing compoundshave on response rates and

behaviors as related to chemical lesioning of hypothalamic areas and
associated neural structures ,

2

REVIEW
OF THELITERATURE
The complexity of gold and its compoundsis of such magnitude-whether chemical, biological,

or behavioral factors are considered--

that it would be most advantageous to consider such phenomenaseparately, prior to attempting to integrate or combine these various
attributes.

A natural starting

point is the history of gold and its

derivatives .
Medical History of Gold and
its Compounds
Gold, as one of the precious metals, was highly regarded as a
medicinal agent i n ancient t i mes.

It was said to be used in the treat-

ment of syphilis at the time of Paracelsus (Drill,
latter

1954).

In the

half of the ni neteenth century, following the emergence of

chemistry as a science, gold and some of its compoundsregained their
popularity as the r apeuti c agents based on a more r.ational basis .
compoundswere widely used in the first
to treat tuberculosis,

Gold

half of the twentieth century

rheumatoid arthritis,

and skin diseases such

as lupus erythrematosis,
Gold chloride was one of the earliest
which were utilized

in medical practice .

Pharmacy (1905), an official

ceutical professions,

compoundsof the metal gold
In Remington's Practice

of

compendiumfor the medical and pharma-

gold chloride was combinedwith nitrohydrochloric

acid to give gold and sodium chloride, the combination of which is
medicinally equivalent to gold chloride , This salt mixture (i.e.,

gold

3

and sodium chloride) was used internally

as an alterative

at a dose of

from 0.005 to 0, 016 gm. By 1917, Holland had published his text, Mediaal
Chemistry and Toxiaology

toxic effects

of gold and sodium chloride are similar to those of

mercuric chloride;
convulsions .

i , e o, gastro-enteritis,

mental disturbances,

and

Soon gold chloride disappeared from the scene as a

medicinal agent ,

A closely-related

prominence in the latter
into disfavor .

(Holland, 1940), in which he stated that the

drug, gold bromide, had come into

half of the nineteenth century, but it too fell

In 1889, Gaubert reported to the French Academythat

gold bromide had a more efficacious

and more durable action in epilepsy

than the other bromides and that it was better tolerated

(Wood, 1940).

Toward the middle of the twentieth century (Wood, 1940), medical
opinion was that the soluble salts of gold are actively poisonous
and that their toxic effects,
be due to their local irritant
the kidneys .

like those of mercury salts,

action on the alimentary canal and on

Perhaps it was due to the lack of reliable

the gold compounds--or possibly other causes--that
continued utilizing

appear to

data about

the medical profession

the gold compoundsi n therapy, although on a smaller

scale .
Currently, gold in its colloidal
particles)
(Drill,

radioactive

(i , e . , finely divided metallic

form is a diagnostic agent for tumor detection

1954), as well as in the treatment of the malignant tumors.

Gold thioglucose and gold thiomalate are utilized
certain cases of rheumatoid arthritis,

frequently

in

and are considered to be the

drugs of choice in such cases by some of the leading rheumalogists
(Goodmanand Gilman, 1965),

4

Colloidal radioactive

gol d can be giv en in small amounts intra-

venously (Root et al o, 1954) i n or der to obtain scintiscan

records

over such organs as the li ver o During the early stages of rheumatoid
arthritis,

gold th i ogl ucose and gol d thiomalate, as well as several

other similar gold compounds, have been demonstrated to be assoc iated
with the reduction of the i nflammatory pr ocess . The patient frequently repor ts rel i ef f rom pai n, but the mechanismof action remains
unknown(Drill,

1954),

A number of stud i es have been conducted to

discover the mechani sm of the act i on of gold compou~dsover the years,
without demonstrable success o
Gold compounds(but not col lo i dal gold) are considered to be
highly toxic by medical pract iti oners (Drill,
duction of the gold compoundsi n arthritic
therapy), the foll owi ng manifestations
have been frequently reported:
gastrit i s, colitis;

1954),

Since the intro-

therapy (i . e . , chryso-

of toxi city (Remington, 1965)

pr uriti s, dermatitis,

stomatis,

and rar ely, bl ood dyscr asi s, hepatitis,

and neu-

rit i s , Although psychi atr i c abnormaliti es have only been i nfrequently
reported (Hartfall,
of the toxic effects

Garl and, and Gold i e, 1937), i n an exhaust i ve revi ew
of gold, Sundeli n (1941) reported cases with central

and per i pheral nervous system mani festat i ons.
from s i mple depression to f r ank psychosi s .
ported a case of meni ngitis

Cerebral symptoms ranged

In 1950, Myerson (1950) re-

as an unusual complicat i on of chrysotherapy .

The Chem
i cal Nature of Gold
and its Compounds
Any considerat i on of the effects
necessitates

of a drug on a biological

system

an invest i gation of the chemical nature of the drug.

One

5

of the reasons is that it has long been knownthat there is a definite
relationship
figurations
systems ,

between the effects of drugs with similar chemical conor structural

similarities

and their actions on biological

Furthermore, the knownsolubility

provide further clues as to possibilities
following admi nistration .
an investigator

characteristics

of drugs

of their distribution

Finally, the chemical structure

also allows

to frequently predict the pharmacodynamicor metabolic

changes which contribute to the final observed effects ,
Metallic gold, the "noble" metal, was knownand utilized
medicinally and ornamentally long before recorded history.
one of the first

both
It was

metals to be ut i lized by mankind (Wood, 1940), and

is found in many parts of the earth, occurring in both free and combined states .

Its chemical symbol is Au.

It is a yellow metal, with

a specific gravity of 19, 3 and atomic weight of 197. 2, and when
finely divi ded, it may show a red, purple, or black color.
valence of one or three when chemically combined,

It has a

In its metallic

form--which includes colloidal gold--the mineral is insoluble and
highly unreact i ve,
Gold chloride, having the chemical formula AuC13 (Wood, 1940),
is usually found in the form AuC13 • HC1•3H
2 0.
yellow crystalline

It is a bright golden-

compoundwhi ch is soluble in water .

hygroscopic and contains approximately 50 per cent gold .
it was rarely prescribed because of its strong irritant
is currently only of historical
is trivalent

interest ,

It is
By 1940,
action and

The gold in the compound

and ionic (i , e, , Au+++), Gold chloride is unstable in

water, so that on long standing it i s changed (or reduced, in technical
terminology) to its elemental state of zero valence; i , e., metallic

6

gold (Bjerrum, 1948).

In an organic material such as sesame oil, this

reaction occurs rapidly so that within hours the gold is in its
1969),

metallic form (USULaboratories,
dity of reduction of the trivalent

In bi ological fluids,

rapi-

ionic gold to it s metallic form

should proceed at an equal or greater rate than that observed with
sesame oil .
Gold thioglucose and gold (sodium) thiomalate are technically
membersof the so-called organo-metallic compoundsbecause they are
composedof the metal gold attached to an organic moiety. What makes
them interesting

and complicated is that the gold in both compounds

is held in what is called a coordination complex. This means that
the gold is ionic in nature--at
chloride,

least to some extent--as

in gold

but is somehowprotected from being reduced by the organic

moiety to which it i s attached o The practical

significance

of this

coordination complex is demonstrated when the compoundis put into
sesame oil, for it remains stable for at least several months (USU
Laborator i es, 1969).

Gold thioglucose has been long known (Merck

Index, 1952a; 1968), and has been marketed under the trade name Solganol
(manufactured by Schering) .

It i s a yellow powder whose aqueous solu-

tions are unstable on long stand i ng, Gold thiomalate is marketed as
Myochrisine (manufactured by Merck) and is a white powder. The fact
that the drugs are currently available from the manufacturers suggests
that they are still

used therapeutically

rheumatoid arthritis

.

on humanssuffering from

The formulas for gold thioglucose and gold sodium thiomalate are
as follows (Remington, 1965):

7

AuS-CH-CH
Na
2 COO

Gold sodium thiomalate

I

COONa•H2 0
CH2 0H

I

H

~~

~;

HO .
H

Gold thioglucose

. S-Au
OH

Gold thioglucose is less soluble than gold sodium thiomalate.
Gold sodium thiomalate, according to Drill (1954), is the only gold
compoundused medicinally which gives an appreciable concentration
of ionic gold .
The Biological Distribution

and KnownEffects of

Gold, Gold Chloride, Gold Thioglucose,
and Gold Thiomalate in
Animals and Man
Gold drugs were knownand ut iliz ed medicinally for thousands of
years prior to any precise scientif i c knowledge of their biological
di stribut i on and biological effects .
was available--almost
in those areas .

Once the biological information

without exception, scientific

For example, digitalis

was knownfor hundreds of

years in England and was associated by all varieties
titioners

gains were made

of medical prac-

with the gout, but once it was found to specifically

heart tissue and to be of a certain chemical structure,
it possible to utilize
the relationships

affect

not only was

it in cardiology on a more rational

basis, but

which had been discovered between the type of drug

and its biologi cal target organ resulted in the discovery of a host of

8

other similar drugs, thus advanci ng the whole field of cardiology.
This same argument applies to the gold compounds. Until their biological effects

were discovered, no meani ngful explanation could be made

for their effects,
tional relationship

fo r example, on operant behavior in rats .
mi ght have been observed (i.e.,

response rate i n relation

to a drug injection);

A func-

a drop or gain in

but without biological

and chemical data, the causal relationsh i p remains obscure .

Conse-

quently, it became imperative to review the data which has been
accumulated to date on gold and i ts compoundso
Metallic

gold in it s colloidal

form was found to be of great use

in medical diagnosis and treatment of malignant tumors.

It was con-

sidered for i nvestigat i on in th i s study because of its continuing
importance i n medicine and its relation
follow in g experiments .

The colloidal

to the other drugs used in the
gold and radioactive

normally admi nis tered i n very small quantities

(e.g n, 5 mg). The

advantage of the isot opic form of administration
that it allows for charting of the distribution
animal.

In 1954, Root and his associates

for our purpose is
of the go1d within the

at the Oak Ridge Institute

for Nuclear Studies (1954) studied the distribution
effects

gold are

and radiation

of in travenous ly administered colloid al gold i n a number of

pat i ents who had been inj ected with the radiogold .

Their results,

usi ng a Geiger tube and radi ograms, i ndicat ed that i n man most of the
gold (60 to 94 per cent) local iz ed i n the liver.

The spleen was

second in its abil i ty to concent r ate gold (5 to 16 per cent); while
the kidneys and lungs and adrenals followed with decreasing concentrations .
effects,

No gold could be found i n the cerebral cortex .
no immediate reactions were noted .

As for clinical

Transient localized

9

tenderness of the liver was noted in the patient who received the largest
dose of the isotope (Root et al . , 1954),
Haigler and Williams (1951) injected
µc

radiogold in doses of 10. 0

to 3 me in albino rats by various routes,

toneal injections .

including the intraperi-

They reported that the gold was phagocytized by

the reticulo-endothelial

cells of the liver,

spleen, lung, kidney, and

bone marrow" Ninety to 95 per cent was taken out of the blood by the
liver and spleen, with very small quantit i es going to reticular
elements elsewhere .
Radioactive gold which was injected
patients

(Bei erwaltes,

intraperitoneally

Johnson, and Lalari,

of the cavity within the first

into human

1957) mixed with the fluid

few hours, after which from 50 to 90 per

cent of the radiogold disapp eare d from the cavity.

Part of the gold

was shown to be attached to surrounding serosa, while a little
gold entered the blood .
greatest

during the first

the total dose per day.

The urinary excretion of gold was low, being
day, but generally less than 0. 04 per cent of
In Russia, Kalistratova,

bryakov (1966) inject ed colloidal
routes of administration

spleen, and lymphatics ,

oral, endotracheal,

and

and accumulated mainly

Gold administered parenterally

four days,

Radiogold has also been injected
mammaryinjection)

The

Their findings indicated that gold was

slowly absorbed from the site of administration

was excreted slowly in the first

Moskalev, and Sere-

gold (198 Au) into white rats .

inclu ded intravenous,

subcutaneous administrations .

in the liver,

of the

directly

into glands (e.g.,

(Berg and Chris tophersen, 1956),

intra-

In these cases, it

was not distr i buted for any appreciable extent throughout the body.
In Berg and Christophersen s study, in which 60 dogs were injected in
1

10

the mammaryglands with the isotope gold, the radionuclide
in the axillary,

cervical,

and latissimus

closely adjacent to the injection

concentrated

dorsi lymph nodes--structures

site.

Such studies of the distribution

of colloidal

gold indicate

that

the final target organ for the deposition of gold is associated with
the route of administration,
compared, identical

so that if several animals are to be

routes of drug administration

are required.

Gold chloride is now known to be too toxic as far as injections
into humans is of concern .
been interested

But over the years, investigators

in the biological

effects

of gold chloride in animals.

Elftman, Elftman, and Zwemer(1946) carefully
distribution

studied the histochemical

of gold following the intraperitoneal

gold chloride into rats and guinea pigs .

administration

A most interesting

tion which they made was that the gold (chloride)
the metallic

of

observa-

was not reduced to

state at the time of deposition in tissues;

he found in those t i ssues refractile

have

but, rather,

granules of gold whose chemical

nature remained undetermined, but may be related to the gold-protein
complexes. The concentration of gold chloride deposition in animal
organs decreased in the following order:

epitheluim of the proximal

convoluted tubules of the kidney; phagocytic cells,
histocytes

including the

of connective tissue in general and the capsules of organs;

the Kupffer cells;

and the reticular

cells of the lymph nodes.

The total amount of gold chloride received by each animal ranged
from 0.034 mg to 0. 43 mg per gram of body weight.
The biological
Orestano (1932).

effects

of gold chloride were also reported by

Orestano's findings were that when gold chloride is

given hypodermically, it is partially

absorbed, producing death with

11

large doses; the rest of the gold chloride (i "e . , the unabsorbed) is
changed to metallic gold.

Rapid i ntravenous injections

minimal lethal dose of 0. 0008 g/kg of body wei ght.

resulted in a

Orestano reported

that the pharmacologic al action was due to the gold ion, which produced
intense hemolysis and hemoglobinuria.

The mineral was fixed in the

red corpuscles more than in other parts of the body.

Orestano

described the follow ing transformation for gold chloride:

complex

gold i on+ gold cation+ metallic gold .
As gold thioglucose and gold thiomalate pre soluble gold compounds,
as is also gold chloride, after injections
gold was deposit ed in largest quantities

of these compounds, metallic
i n the kidneys, which was

in strik in g contrast with the larg e amount of gold that localized
in the liver following injecti ons of colloidal
Buchanan, and Freyberg, 1942).

gold compounds(Block,

Gold was also located in the heart,

lungs, and spleen, as well as at the inj ect i on sit e, following administration

of gold thioglucose and gold thiomalate .

So far, we have been dealing with systemic abdominal distributions,
which are the limiting distributions

for colloidal

chloride as indicated by the available data .

gold and gold

In addition to the

abdominal distr ibutions of gold following the administration of gold
thioglucose and gold thiomalate,

it was demonstrated by Mayer (1960)

and Wagner and DeGroot (1963) and subsequent investigators

that the

brain it self is invaded by these compounds. Gold deposit i on in brain
tissue i s of great interest

to psychologists because of the possi bility

of associated behavi oral effects .
Gold thioglucose and gold th i omalate, which contain the metal in
chelate linkage (Beckman, 1958), although not the only metals which

12
can penetrate the brain, are of particular

interest

to psychologists

because studies have linked them with abnormal hypothalamic functioning and some nutritional

problems (Mayer, 1960). The first

study

(Marshall, Barnett, and Mayer, 1955) demonstrated that gold deposited
in the ventro-medial nucleus (VMN)of the hypothalamus after a single
large injection

of gold thioglucose int o mice.

In addition to the

VMNlesions demonstrated by Marshall, Barnett, and Mayer (1955),
Liebelt and Perry (1957) demonstrat ed that significant

lesions were

also induced in the lymbic system of mice (i .e . , fornix, ventral
psalternus,

and primordial hippocampus), as well as in the hypothalamus.

By 1960, Swartz, Christian,

and Andrews (1960), using radioactively-tagged

elements (i.e . , Au 198 and S32), observed the sites which gold and thioglucose each occupied at various intervals
gold thioglucose injections.

up to 48 hours following the

They found labeled gold in the mouse's

cerebrum, hypothalamus, and hindbrain .

Mayer's (1960) work at that

period indicated that hypothalamic lesions were produced in rats by the
administrat io n of gold thioglucose,

as well as i n mice, but the rats

did not survive the massive doses because of toxic effects .

Thus,

Mayer concluded that while the lesions can be induced by gold thioglucose
in rats,

obesity cannot, since it requires the survival of the animal.

In 1962, Debons et al , (1962), utilizing

histological

and autoradio-

graphic techn i ques, demonstrated that there was a predominant accumulation
of gold in the middle section of the brain, which included the hypothalamus.

The radioautographs indicated that although gold thiomalate

penetrated brain tissue and was deposit ed as gold, the disposition was
diffuse in comparison with gold thioglucose,

in which the heaviest

concentration was with i n the VMN
of the hypothalamus. The animals which
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received gold thioglucose, but di d not develop hypothalamic obesity,
characterized by hyperphagi a and subsequent obesity, had the lowest
content of gold in the mi dsegment (whi ch included the hypothalamus).
Debons et al , (1962) also injected 75 mi ce wi th gold thiomalate.
Although none of the 75 mi ce became obese, there was a significant
amount of gold noted i n the bra i ns of the gold thiomalate-treated
The distribution

mice.

of gold i n the br ai n of the gold thioglucose-treated

non-obese ani mal was too diffuse to be localized in discrete areas
even after prolonged exposure of r adi oautographs .

It was also noted

in this study that there was no r adi oautogr aphi c evidence of gold
accumulation in the hypothalamus of t he animals which were treated with
gold thioglucose but did not become obese; nor di d any of the gold
thiomalate-treated

ani mals show radi oautographic gold localization

the hypothal amus, al though gol d was di str i buted diffusely

in

throughout

the brain in every case ,
Mayer (1960), af t er i nj ecti ng sever al hundred mice wi th varying
dosages of organo- metall i c gold compounds, was abl e to establish
statistics

for l etha l dosages ,

Gold thiog l ucose was demonstr ated to be the only gol d compound
to produce obesi ty i n the mouse, and the l ethal dose (i , e . , LO 50) was
dete rmined to be approxi mat ely 1. 0 mg per gr am of body weight--a
dosage whi ch pr oduced obesit y i n approximately 50 per cent of mice
following inject i on,
Although the hypothal ami c area i nvolved is often very large, only
hyperphagia appears to resu l t (Mar shall,

Barnett, and Mayer, 1955), and

it appears that the presence of the gl ucose component in the gold
thioglucose molecule makes th i s restricted

hypothalamic portion of the
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blood-brain barrier much more permeable to this compoundthan to compounds not containing glucose.

The hypothalamic area containing the

feeding centers had been previously postulated to contain "glucoreceptors"

(Mayer, 1953)o The lesions formed were permanent in

animals which in fact became obese, but were not apparent in animals
unsuccessfully injected o Gold thiomalate,

though as toxic as gold

thioglucose (Mayer and Marshall, 1956), did not cause obesity or
hypothalamic lesions o Mayer and Marshall (1956) also tested sodium
thioglucose along with the gold thiomalate.
gold thiomalate injections

Sodium thioglucose and

of varying dosages did not produce obesity,

while gold thioglucose (Marshall, Barnett, and Mayer, 1955) was
responsible for observed obesity.

Mayer and Marshall (1956) had shown

that rats appear to be more susceptible

to the toxicity of gold

compoundsin general .
Brain damage, as a cause of gastric
first

ulceration

in animals, was

demonstrated by Schiff in 1846, and later confirmed by many

investigators.

More recent work indicates

that the hypothalamus plays

a prominent role in the formation of such lesions.

Consequently,

Deter and Liebelt (1962) injected rats intraperitoneally

and intra-

muscularly in dosages of 0, 2 mg to 0. 5 mg per gram of body weight
and reported that a s i ngle injection

of gold thioglucose produced

gastric ulcers and hypothalamic lesions in 100 per cent of injected
rats if proper experimental condit i ons were chosen.

Doses of gold

thiomalate and gold chloride, which killed animals within 24 hours
(Deter and Liebelt,
lesions;

1962), produced neither hypothalamic nor gastric

although in the case of gold chloride,

animals injected with

only Oo04 mg per gram of body weight of the compoundkilled three out
of the 10 rats within 24 hours following injection.
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Gunter and Ivy (1949) tested Hench's (1940) hypothesis that the
ameliorating effect of gold in rheumatoid arthritis
gous to, if not basically
jaundice .

is perhaps analo-

i dent i cal wi th that induced by intercurrent

Gunter and Ivy used two dogs which were in good health,

weighing 13. 2 and 14. 1 kg, as the i r subjects ,

They injected gold

thioglucose and gold sodium th i omalate to both dogs for a period of
three weeks. A total of 1500 mg of the combined drugs were administered
to each dog (i . e, , 800 mg of gold sodium thiomalate and 700 mg of
gold th i oglucose) .

They followed the gold administrations

with labora-

tory tests for liver function and the i r data indicated that in no
case did any of the liver function tests show a variation beyond the
normally accepted values .

Thei r results

did not support Hench's

hypothesis that a case of jaund i ce follow i ng gold injections
relieve a patient's

suffe ri ng.

should

No behavi oral changes were reported

by Gunter and Ivy (1949), although i t should be noted that in terms
of the dog's body weight (i , e , , 14 kgms), and knowing that gold thioglucose has an LD50of 1 mg per gm of body wei ght for mice (Mayer,
1960), a div i ded dosage of 1500 mg represented approximately 10 per
cent of the comparabl e lethal dose,

Stil l, this amount was not suf-

f i cient to produce extens i ve hypothalami c effects
In rats,

in the animals.

admi ni strat i on of subletha l dosages of gold thioglucose

(i. e , , 0. 4 mg per gram of body wei ght (Wagner and DeGroot, 1963))
produced bilateral

les i ons i n the ventromedi al aspect of the hypothalamus

in 90 per cent of the rats,

although obesi ty did not result at this

dosage level .
Chang and Persell i n (1968) injected gold thiomalate into guinea
pigs (2. l mg gold sodi um thiomalate per week) and reported that the
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experimental subjects gained significantly
trols .

more weight than the con-

They detected gold in the hypothalamic and thalamic sections

of treated animals when they used the techni que of neutron-activation
analysis.

Brain sections from control animals did not contain gold .

Chang and Persellin's

study (1968) extended the species generality

of

the brain effects of administration of gold compounds.
Cortell and Richards (1942), using rat subjects,

demonstrated

the development of tolerance to gold salts in rats, using the survival
method.

They showed that rats given suble t hal dosages of gold sodium

thiosulfate

and of gold sodi um th i omalate could tolerate

ordinarily

lethal dosages of these compoundswhen subsequently administered.
Denko and Anderson (1944) also used a similar technique to test the
toxicity

of gold compoundsand noted that sublethal dosages of gold

thioglucose showed a decided r i se i n blood nonprotein nitrogen values
(a technique for quantifying one form of toxi ci ty) which returned
to normal the fifteen t h day. Whenthe dosages of gold thioglucose
were repeated on these ani mal s, blood nonprotein nitrogen values
remained normal .

A third dose of 75 mg also showed no appreciable

rise i n the blood nonprotei n nitrogen value ,

Gold compoundswere also

frequently swi tched i n th i s procedure, thus enabling Denko and
Anderson (1944) to demonstrate both a direct tolerance and cross
tolerance for the gold compounds.
There are also a number of related metabolic factors affecting
the deposition (and perhaps the transport)

of gold thioglucose.

For

example, Edelman et al . (1965) have gathered data which indicate
that glucose concentrations in the blood of the animal subject that
prevailed at the time of the gold thioglucose injection was directly
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correlated

with the hypothalamic uptake of gold, with the extent of

the hypothalamic lesion that resulted,
subsequent hyperphagia and obesity ,

and with the severity of the
They found that hyperglycemia or

high blood sugar was associated with an increased gold deposition
throughout the brain ,
Likuski, Debons, and Cloutier (1967) found that the glucose
inhibitors,

2 deoxy-0-glucose and 2-amino-2 deoxy-0-glucose, both

markedly inhibited

gold thioglucose-induced

hypothalamic obesity.

Likuski, Debons, and Cloutier (1967) confirmed the hypothesis that a
glucose inhibitor

(such as 2 deoxy-0-glucose) interacts

the postulated satiety
nificantly

center ,

with cells in

Such metabolic inhibitors

could sig-

affect the outcome of the gold thioglucose injection

they should occur in appreciable quantities
system at the critical

time.

if

in the animal's vascular

As for the environmental variables,

Likuski, Debons, and Cloutier (1967) noted that the room temperature
at the time of the gold thioglucose injection

plays an important role

in the incidence of obesity, obtaining a 100 per cent incidence of
obesity by maintaining a constant room temperature of 21 C ± 2 Cat
the time of the gold thioglucose administration .
Behavioral Effects of the Gold Compounds
Behavioral effects
able or toxic ,

Any undesirable behavioral characteristic

defined arbitrarily
ministration
arbitrary ,

of drugs may be considered to be either desir-

as behavioral toxicity

of a particular

drug .

may be

if it should follow the ad-

Such a definition

The quest i on arises whether a more rational

would be most
approach to the

subject may be taken ~ The answer suggested is that the term behavioral
11
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toxicity"

could be a general term for behavior resulting

cific drug administration

from a spe-

in which the consequent behavior is in some

manner non-adaptive for a particular
examples would be such effects

memberof a species.

Appropriate

as loss of thermoregulatory control

for a species whose home is in a cold environment, or muscular spasms
in an animal which normally has to maintain itself

at treetop level ,

In such a context, behavioral toxic i ty becomes meaningful and, furthermore, clarifies

what might be considered appropriate behavioral effects

for a particular

animal in a given environment ,

The behavioral effect which brought the gold compoundsinto
prominence for psychologists
accidental

and nutritionists

was the result of an

finding made by Brecher and Waxler (1949) 20 years ago.

A number of behavioral effects

had been noted to be associated

with hypothalamic lesions prior to 1949; i . e . , hyperexcitability
(Hetherington and Ranson, 1942); abnormality of the reproductive
organs, and of mating behavior (Bard, 1940; Dey, 1943).
Brecher (1949) injected mice with the organo-metallic

Waxler and

chemical gold

thioglucose in order to study the drug's toxicity .

They noted that

within days, the animal's size markedly increased ,

As a result,

decided to carefully

investigate

they

the phenomenon. Brecher and Waxler

administered a single i ntraperitoneal

injection

gold thioglucose to albino mice, with resulting

of 25 mg to 35 mg of
marked weight gains

in about 10 to 14 weeks. A post-mortem analysis was conducted for
total body lipids,

proteins,

water, and ash.

They concluded that the

gain in weight in the mice was primarily due to an increase in adipose
tissue.

Brecher and Waxler (1949) described the characteristics

of

their gold compound. They stated that it was made up of 50 per cent
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gold, was unstable in water, and was hygroscopic.

To maintain the com-

pound in a stable form, they used sesame oil as the vehicle . Although
gold thioglucose is fairly

stable in aqueous solutions

(Remington,

1965), gold thioglucose in sesame oil allowed for even greater stability.

Brecher and Waxler (1949) determined that the lethal dose,

arbitrarily

defined as the dose at which 50 per cent of the animals

die, was 40 to 50 mg intraperitoneally
gms.

for mice weighing 20 to 25

Fifty to 70 per cent of their animals survived doses of 35 mg

of gold thioglucose,

and 90 per cent survived dosages of 25 mg.

animals survived doses of 12 mg injected
ities

from the administration

during the first

intraperitoneally.

All

Fatal-

of gold thioglucose generally occurred

three to four days.

There was no further mortality

among those animals which survived one week,

Only about one-third to

one-half of the gold thioglucose-in j ected animals showed unusual weight
gains.

Animals that failed to show significant

weight gains by the

eighth week were given another 25 or 35-mg dose of gold thioglucose.
Significant
reinjected

weight gains were subsequently observed in a number of
ani mals.

Animals, when given injections

gold thioglucose intraperitoneally

of only 5 mg of

twice a week until a total of 150

mg were given, fa i led to show any significant

weight gains.

All

animals used in the above experiments were killed at the end of 14
weeks,

The viscera and the brains of both injected and control animals

were examined microscopically .

Except for centrolobular

infiltration

of the liver in obese animals, no anatomical lesions were formed in
the organs examined.
The significance

of hyperphagia (overeating)

following the administration

and subsequent obesity

of gold thioglucose in mice subjects has
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stimulated research efforts by behavioral investigators

and medical

researchers concerned with nutrition.
Following the investigations
sibly the earliest

of Brecher and Waxler (1949), pos-

use of operant procedures to study hypothalamic

obesity was that of Miller, Bailey, and Stevenson (1950).
date, it was knownthat gold thioglucose injections

By this

were followed by

obesity in the mouse (Brecher and Waxler, 1949), but hypothalamic
lesions had not been associated with the obtained data.
Miller, Bailey, and Stevenson (1950) stereotaxically

induced

hypothalamic lesions in their subjects and sought to answer the question of whether the marked increase in food intake produced by the
lesion in the hypothalamic subject would be accompanied by increased
performance in a variety of behavioral tasks motivated by hunger. The
following procedures were used:
by food at five-minute intervals;

(1) rate of bar pressing, reinforced
(2) amount of electric

shock required

to prevent approach to food; i .e . , negative reinforcement in an
approach-avoidance situation;
of a bitter

and (3) amount of food eaten in spite

taste (produced by mixing quinine with the food).

Miller,

Bailey, and Stevenson (1950) concluded that in ad libitum feeding
situations,

animals ate increased quantities

of food following lesions,

but generally did not work for the same quantities
udrive

11

of food; i .e. , the

to obtain food--as indicated by performance--was weak in

comparison with expectations from the consummatorybehavior noted in
ad libitum feeding situations.
The likelihood of a specific causal or functional relationship
between a brain lesion and subsequent obesity in an animal subject,
with an accompanyingexplicit

statement of the mechanisms involved,
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was explored in 1955. In that year, Bates, Zomzely, and Mayer (1955)
noted that the instrumental behavior of overeating (hyperphagia) in
obesity was not necessarily simple, as the hyperphagia may be the
secondary result of an abnormal fat metabolism--either
of synthesis,

increased rate

decreased fat mobilization and oxidation, or an imbalance

between the two, with a net gain in favor of synthesis.

It could

also, they hypothesized, be due to an entirely

cause.

different

A most enlightening study by Anliker and Mayer (1956) utilized
operant procedures to measure feeding behavior patterns in demonstrating
a change from normal feeding to increased intake at each meal with
gold thioglucose-injected

mice" Mayer (1953), who had written on the

genetic, traumatic, and environmental factors in the etiology of
obesity, and Anliker (Anliker and Mayer, 1956), undertook this investigation " Their subjects were mice with three types of obesity produced by different
stereotaxically

methods; i , e , , hypothalamic obesity, produced by

lesioning the ventromedial nuclei of the hypothalamus;

gold thioglucose obesity, resulting
with gold thioglucose;

treatment

and hereditary obese hyperglycemia syndrome,

a Mendelian recessive characteristic
11

from a single injection

that originated from crossing of

V stock" males and C57 Bll6 females , The cumulative records of
11

11

Anliker and Mayer's study represented prolonged studies of several
animals of each type and illustrate

the food intake patterns.

Anliker

and Mayer (1956) were able to demonstrate that the over-all rate of
feeding was greater for the hyperphagi c mice--i ncl udi ng go1d thi ogl ucoseobese mice--than for the normal controls;

and that waves or cyclic

changes in rates of feeding were characteristic
were absent or barely discernible

of normal mice, but

in the hyperphagic mice. They
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concluded that gold thioglucose-obese animals and hereditary-obese
animals are the same, or approximately so, This conclusion was different from the one reached by Bates, Zomzely, and Mayer (1955), when they
noted that large differences existed between hereditary-obese
and their siblings made obese by a single injection
in relation

mice

of gold thioglucose

to food intake and spontaneous exercise .

Schmaltz and Issacson (1968) stereotaxically

produced caudate

lesions in rat subjects to test for retention and relearning of an
operant reinforcement schedule.

Transient, post-operative

impairment

was noted, and recovery on the schedule was generally noted by the
tenth post-operative
from the transient

day.

It was noted that impairment could be noted

behavioral decrements; but the brain-damaged

subjects recovered, although recovery required at least a week or two
for reestablishing

the baseline .

Such results have possible implica-

tions for drugs damaging brain tissue .
In 1960, Mayer reported that the hypothalamic lesions induced by
gold thioglucose in mice are much more "purely" hyperphagic than
lesions induced in the same area by electrolytic

coagulation.

Although

gold thioglucose lesions were widespread, they appeared to be selective.
Mayer (1960) also reported that it is well knownthat there are all
sorts of disturbances in functions other than food intake in animals
in which les i ons have been induced electrolytically
instrument; but by contrast,
seem to be only hyperphagic.

with a stereotaxic

animals made obese with gold thioglucose
They br eed, have normal litters,

and

nurse their young,
Mayerls report (1960) of normal breeding in mice following gold
thioglucose administration was not supported subsequently, for in 1966
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Rudali and Silberman (1966) injected

female AkRmice intraperitoneally

with gold thioglucose and subsequently observed that they were sterile.
With male mice, they reported sterility

in spite of normal spermato-

genesis .
Although hyperphagia was the most frequently

reported behavioral

effect in mice since Brecher and Waxler1 s investigations
other behavioral effects
DeGroot (1963) ,

of 1949,

of a toxic nature were reported by Wagner and

Following the injection

of 63 male Long-Evans rats

with varying dosages of gold thioglucose

(Wagner and DeGroot, 1963),

varying from 0.1 to 0.75 mg per gram of body weight, within 12 hours
after injection

all rats exhibited aphagia, adipsia,

of lowered body temperature (i.e.,
to a variety of stimuli,
which invariably
thioglucose.
toxicity

shivering),

enuria, evidence

increased sensitivity

mild tremors, and the onset of convulsions,

preceded death in rats given lethal dosages of gold

Such symptoms are additional

attributed

manifestations

of behavioral

to gold thioglucose administration.

In the case of gold thiomalate,
to the compoundduring arthritic

reactions

therapy.

have been attributed

Strauss,

Barrett,

and Rosen-

berg (1950) report that toxic reactions to gold in humans resulted
from small amounts in some cases and large amounts in others.
patient,

only 20 mg of gold were sufficient

in another, toxicity

In one

to induce a serious reaction;

did not appear until 7900 mg had been administered.

In 86 per cent of the cases, the toxic reaction to gold consisted of
pruritis,
hepatitis,

dermatitis,
or nephritis

or stomatitis . Occasional bone marrow depression,
was reported ,

In the case of gold, as had been suggested (Root et al . , 1954), the
administration

of Au1 98 intraveneously

causes little

untoward effects
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in the patient.

In a few cases (Root et al . , 1954) there was anorexia

for a few days; and in one patient,
function tests showed no significant

transient

liver tenderness.

Liver

changes following the gold admin-

istration .
Gold chloride is now known to be quite toxic, so that the most
predictable

effect following appreciable dosage administration

would

be the death of the subject.
Behavioral toxicity

has already been previously attributed

gold thioglucose administration
central and peripheral
and polyneuritis
1946).

nervous system manifestations

leading to flaccid paralysis

Such disorders,

ment, fall

to humans; i . e . , psychiatric

to

disorders,

(Sundelin, 1941),

of all limbs (Leiper,

not conducive for adaptation to the environ-

under the behavioral toxicity

Although most toxic effects

classification

.

of gold compoundsin the case of

human subjects are expressed as verbal expression or operant behavior,
an interesting

exception (i , e . , electro-physiological

reported by Patterson and Dale (1966).
EEGfrequencies,
toid arthritis

particularly

evidence) was

They reported that more abnormal

fast wave findings,

appeared in rheuma-

patients who had received large amounts of gold over a

period of many years .
It became evident from data obtained from many sources that the
neuroanatomical, neurophysiological,
administration

and behavioral changes following

of gold compoundswere much more complex than they were

previously believed to be.

From Mayer's (1960) work, it was indicated

that gold thioglucose lesions are associated with hyperphagia and
obesity in mice, but not with gonadal dysfunction.
(1957) data indicate

that significant

Liebelt and Perry's

lesions were induced in the
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limbic system, as well as in the hypothalamus, thus directing
research into the area of limbic damaged tissue,
emotional changes.

Swartz, Christian,

future

and possibly associated

and Andrew's (1960) administra-

tion of gold thioglucose into mice indicated a widespread deposition
of gold into brain areas, with the probability
and reliev i ng pain through the alteration

of pain pathways.

et al 's . (1962) data demonstrated differential
brain regions following the administration
gold thiomalate and the differential
amic areas following the injection
thiomalate .

of modifying behavior
Debons

deposition of gold in

of gold thioglucose or

gold deposition in the hypothalof gold thioglucose and gold

Brecher et al . (1965) obtained experimental data which

indicated that the ventro-medial nucleus of the hypothalamus did not
have to be the damaged tissue associated with the subsequent obesity;
but rather,

that the glucoreceptive

anatomical site .
glucose inhibitors
sition
tissue .

sites may be widespread as to

Likuski, Debons, and Cloutier (1967) showed that
can interact

with the hypothesized anatomical depo-

s i tes, thus prevent i ng the fixation

of gold to hypothalamic

Reynold's (1965) data and his proposed irritative

theory,

although in agreement with the experimental findings of widespread
gold deposition,

allowed for the irritation

but contradicted

the theoretical

of the lateral

hypothalamus,

foundations of the old explanatory

hypothesis for the mechanisms controlling

food intake .

This contra-

diction created a need for new experimental approaches and effort .
Finally,

Hoffman and Whistler ' s (1968) data on the effects

cose--which were assumed to be non-contributory--turned
metabolically

significant,

of thioglu-

out to be quite

causing a temporary glucosuria and hyper-

glycemia, and thus complicated the interpretations

of the effects
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which followed the administration

of gold thioglucose

into animals and

humans.
Cox, Kakolewski, and Valenstein's

(1969) most recent study of

ventro-medial hypothalamic lesions and changes in body weight and food
consumption in rats was closely allied
State University.
of age.

to that undertaken at Utah

Subjects were both male and female rats,

four months

After two weeks of baseline measurements, Cox, Kakolewski,

and Valenste i n's experimental animals received bilateral
the ventro -medial hypothalamus, utilizing

a stereotaxic

lesions of
instrument.

Controls were subjected to the same treatment as the experimental
subjects--including

free feed--except

omitted in the case of the controls .
significantly

lesioning was

Female controls did not vary

in weight duri ng the three weeks following surgery

from their initial

weight (i . e., 275 gms).

medial hypothalamic damaged subjects,
an initial

that stereotaxic

In the case of the ventro-

weight averages increased from

weight of approximately 275 gms to a final weight of slightly

over 350 gms--indicating

hyperphagic behavior .

Lesioning of the ventro-

medial hypothalamus (Cox, Kakolewski, and Valenstein,
to substantial

1969), then, led

demonstrable weight gain in female rats within a three-

week period follow i ng stereotaxic

lesioning of the ventro-medial

hypothalamus.
The Characteristics

of the

Measurement Technique
An essential

consideration

with operant procedures, particularly

an escape schedule (since the escape schedule was utilized
studies),

in these

was the ratio length effect noted in Dinsmoor and Winogard's
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( 1958) study.

The responding rate of subjects on shock schedules was

analyzed after first

stabilizing

the animals for several sessions at a

given level of current and then taking a new series of readings at
higher or lower shock levels.

Their data indicated that as shock was

i ncreased, response rate increased,

and visa-versa.

Although the rate

of response generally increased with increase in shock intensity-assuming that the subject did not stop responding altogether--there
was an important length of ratio effect which was of particular
nificance with drug studies .
under different

sig-

Winogard (1965) studied escape behavior

fixed ratios and shock intensities.

that for a subject on a long fixed ratio

(e.g.,

His data indicated

FR20), the rate is

lower than for a short fixed ratio (e . g. , FR5). The difference
rate for different

length schedules (Winegard, 1965) might be attributed

to breaks occurr i ng after the ratio run was under way.
or pauses have been called "strain"

by such investigators

Ferster and Skinner (Winogard, 1965).
that on long ratios

in

These breaks
as Boren and

From such data it can be assumed

(e.g . , FR20), if rates of response by the subject

are very high, the strain will be eliminated and drug effects
be less than, for example, the same FR (ratio)

should

in which the subject

responded at a lower rate and, consequently, strain was notable .
a s hort fixed ratio there was generally no strain

With

and the rate of re-

sponding was at a higher rate (Winogard, 1965) so that less disruption
by drugs was to be expected .

It is evident from Winogard's data that

rate changes following drug administration
be comparable to those for a short ratio,
bene fit by using at least one additional

on a long ratio might not
so that the investigator

might

ratio length, either much longer

or s horter than the main ratio for the experimental schedule.
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The dose-curve relationship

(Thompsonand Schuster, 1968) is a

very useful conventional pharmacological technique for measuring
behavioral changes in the experimental session following the injection
of a drug .

It is often assumed, consequently, that the behavioral

changes noted on the curve during the session are due to, or
associated with, the drug action.
In the case of drugs such as the gold compounds, however, the
concept has to be stretched

to include post-experimental

drug sessions.

Under such conditions,

samples of behavior demonstrated in the curves

before drug injection

must be compared with sample sessions after the

injection.

In this connection, for example, Barnes and Stoner (1959)

studied the action of triethyl

tin .

Rats were given a single dose at

about the LD50for that drug, producing a transient
after which the animal at first

narcotic action,

recovers (Barnes and Stoner, 1959),

and then over the next two to three days it becomes quieter and
progressively

weaker and dies.

to operant procedures the first
sessions--although
individually

Obviously, should such rats be subjected
session, or even the first

producing a definite

it provides insufficient

several

drug dose-curve effect--taken
data for interpretations,

and

would be quite misleading if the before and after records were not
studied session by session to note in what sessions the drug had its
maximumor minimumeffects ', even though only one injection

had been

administered.
Barnes states

the problem when he notes that

many drugs that affect behavior can have the most rapid
and dramatic effects which are nevertheless completely
and often equally rapidly reversible . A number of
centrally acting poisons, on the other hand, act much
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more slowly but in many cases irreversibly

, (Barnes,

1964, p . 172)

The latter

statement possibly applies to gold compounds.
Summaryand Interpretations

of the

Gold CompoundsLiterature
The chemical characteristics

of drugs, as well as their distribu-

tion in the organism and their biological,
effects,

when considered in relation

earlier--allow

for a rational

to each other--as

interpretation

providing a framework for inferences

mentioned

of effects,

as well as

and predictions.

Gold thioglucose and gold thiomalate,
some not-too-well-understood

as well as behavioral

existing

as chelates,

in

fashion maintain the ionic or partly

ionic state of the gold part of the molecule, and thus provide a
possibility

for a slow but reactive gold interaction

materials

prior to some sort of deposition

pounds are both soluble,

with biological

in the tissues.

and since reactions

The com-

are protected,

the drugs

may travel extensively

throughout the body of an animal or man prior to

reacting with tissue .

Wagner and DeGroot1 s (1963) data, in which

animals were sacrificed
histological

within 48 hours after treatment,

evidence for hypothalamic lesions,

drug must distribute

itself

clearly showing that the

widely within that time.

passing the blood-brain barrier,

Swartz, Christian,

Andrew's (1960) data indicated that gold thioglucose

Gold chloride,
reactive,

This would include

in order for the compoundto reach

its deposition site within the hypothalamus,

up in high concentrations

provided

and

could be picked

in the brain within two hours.

being a trivalent

gold compound, is the most

but it has not been localized in brain tissue.

As Orestano
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(1932) claimed, it was highly reactive,
widely as it became distributed,
fatality

.

Gold chloride,

damaging tissues

rapidly and

with renal damage that led to

then, might be considered the most toxic of

these gold drugs, although the toxicity

must be restricted

to abdominal

areas at the current state of our knowledge.
Hoffman and Whistler's
gold thioglucose

(1968) finding that the thioglucose part of

increases the glucose levels of the blood temporarily

and Deter and Liebelt's

(1962) finding of gastric

lesions associated

with the hypothalamic lesions both contribute markedly to the anorexia
which is reported when higher dosage levels are administered (Wagner
and DeGroot, 1963).
In the case of gold thiomalate,
drug in structure

in spite of the similarity

to gold thioglucose

of the

it is known to diffuse in all

areas of the brain (Debons et al . , 1962), rather than concentrating
in the VMNof the hypothalamus (as with gold thioglucose);

and from a

chemical point of view, it is more soluble and more ionic than gold
thioglucose .
and toxicity

Such a chemical difference

for gold thiomalate in comparison with gold thioglucose .

Behaviorally,
tively

colloidal

inert status,

thiomalate administration

death; while gold thioglucose and gold
For example, the

have been followed by clinical

condition is improved (Drill,

centage of the cases, particularly

where toxicity

reports that the subjective

with the joint

should lead to deteriora-

should fall in between.

drugs in human administration
in which the arthritic

gold would seem to fall into the rela-

gold chloride toxicity

tion of behavior and finally

frequently

can lead to greater reactivity

disease is reduced.

reports

1954) in a per-

occurs.

The patient

experience of pain associated

Gold thiomalate has also been
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used routinely

for years in animal arthritis

with reports of observed

improvement in the locomotion of the animal (Fennel, 1969), thus
demonstrating behavioral modification effects .
The most obvious difference
thioglucose
chloride)

between gold thiomalate and gold

and the other two gold compounds (i . e . , gold and gold
is that the two organic-metallic

compoundsdeposit in both

the body and brain of most species studied so far; but in the case of
gold and gold chloride,
reportedly

whatever are its systemic effects,

do not penetrate

the drugs

the brain.

An important consideration

in relation

to all gold compounds

deals with what the pharmacologists call pharmacodynamics. Typically,
drugs (e . g. , phenobarbital)
distributed
centration

are soluble in biological

tissue,

are

rather evenly except for the target organ (where the conis assumed to be greater),

and do their work (i.e.,

codynamics) by temporarily depressing or stimulating
or organ, and are subsequently eliminated.
compounds, the most obvious implications

pharmo-

a particular

tissue

In the case of the gold
for a pharmacodynamic explan-

ation must include the fact that gold compoundsare quite different
from most classifications
gold injection

of drugs in that the final end-product of a

includes the deposition of metallic

Not only can function be altered
probability

of differential

by such tissue alterations,

in effect

produce unpredictable

could conceivably produce

in the same manner that neuro-surgical
after-effects

on patients.

of gold would tend to produce variability
relationships

for the drugs .

but the

deposition of the gold on a particular

occasion following drug administration
variability

gold within tissue.

operations

This characteristic

in demonstrable functional

Furthermore, the evidence for tolerance

32

of gold compounds (Cortell and Richards, 1942; Denko and Anderson,
1944), using a non-protein nitrogen index, would be expected to be
reflected

behaviorally

in a more constant response rate over sessions

following the development of tolerance

to the toxic drugs.
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STATEMENT
OF THEPROBLEM
A major problem of interest

their effects

on different

in relation

to gold compoundsand

species is the apparent discrepancy between

the brain lesion and obesity produced in mice following administration
of a large gold thioglucose dose and the apparent absence of similar
phenomena in rats and other species,
gold thioglucose
arthritis

injections

of patients

have not been associated

Hypotheses stated in relation
data collection
1.

including man.
suffering

The therapeutic

from rheumatoid

to date with brain lesions or obesity.
to the basic research design and

techniques include the following:

Gold thioglucose and gold thiomalate effects

tion are different

following injec-

from those obtained either from gold or gold

chloride ,
2.

Gold thioglucose and gold thiomalate should decrease response

rates due to the neurological
3.

Gold chloride,

damage they induce.

because of its reactivity,

should be highly

toxic to rats.
4.

Colloidal gold, because of its inertness,

should produce no

behavioral effects .
5.

Gold thioglucose-lesioned

(or assumed to be lesioned) subjects

should not react in the expected fashion under conditions in which
anaphylactic shock would be expected.
6.
istration

Some differences

in behavior might be expected following admin-

of gold thioglucose and gold thiomalate because of their

chemical differences

and different

brain deposition .
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7.

Paralleling

the data indicative

of biological

tolerance for

gold compounds (Denko and Anderson, 1944), behavioral tolerance or
adaptation following repeated administration

of either gold thio-

glucose or gold thiomalate should be demonstrable.
8,

Hyperphagi a and weight gain in rat subj ects could follow

admini stration

of heavy dosages of gold thioglucose .
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EXPERIMENT
I
Since colloidal

gold strongly contrasts with gold thioglucose and

gold thiomalate in reportedly being chemically inert,
a gold control.

Sesame oil served as a vehicle control.

chemical difference,

lesser extent .

Based on this

it was expected that gold would affect the animal

in the same manner behaviorally

oil.

it was used as

as other gold compounds, but to a

Gold chloride was reduced to elemental gold in sesame

It was assumed that the gold was primarily of colloidal

size

after reduction ,
Method
Subject
A single Long-Evans female rat (Rl2), three months of age, served
as the subject .

The rat had not been previously used as an experimental

subject .
Apparatus
The apparatus consisted of a relay-timer

switching apparatus and

an operant conditioning chamber equipped with a lever, stimulus lights,
and a scrambling grid for shock delivery.
apparatus is programmedfor controlling
addition,

The relay-timer

switching

behavioral contingencies .

a cumulative recorder allowed for event recordings,

lever-pressing

such as

responses.

Automatic recording of the number of responses emitted by Sis
programmed, as well as number of reinforcements,

In

time out (or relief
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from shock) delivered,

inter-response

of time-out responses; i.e.,

times (IRT's),

and the number

responses following shock termination .

Procedure
In the Escape Schedule utilized

in this experiment, the operant

behavior or response is reinforced by the termination of an unconditioned
negative reinforcer,
1968).

such as electric

The negative reinforcer

shock (Thompsonand Schuster,

or shock (i.e . , S-) controls the occur-

rence of the responses.
The establishment of a baseline,

incorporating

the response

rates data of a number of sessions prior to administrating
allowed for utilization
serve as its own control,
for interpretation
injections,
sessions .

a drug,

of the procedure in which e~ch subject could
with baseline data serving as the criterion

of response rate variations

as well as variations

associated with drug

during the post-drug injection

(See Cox, Kakolewski, and Valenstein,

At each experimental session,

1969.)

the subj ect (Rl2) was lifted

out

of its home cage, weighed, carried i nto the experimental room, and
placed in the operant chamber (after being observed on the balanced
beam apparatus).
the apparatus.
utilizing

The experimenter (E) left the room after turning on
This initiated

a 50-minute experimental session

an Escape Schedule ,

The initial

experimental sessions consisted of training

to respond to terminate shock.

the rat

This was accomplished by initially

terminating shock after each bar press (i . e., FRl or CRF), followed
by increasing the number of bar presses which had to be emitted in
, order to terminate the shock for 30 seconds ,

The subject was trained
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to a terminal level of a fixed ratio of 20 responses (i.e.,
followed by a 30-second relief
termination of a session,

or time out from shock.

FR20),

Following

the animal (Rl2) was returned to its cage

where it had free access to food and water at all times.
The baseline response rates for Rl2 varied from 20 to 75 responses
per minute--a rather wide baseline base--prior
series

(Figure 1).

to initiating

the drug

The last pre-in j ection session 1 s data (i . e., 75

responses per session) indicated that Rl2 had attained

a rapid and

dependable response rate pattern on an FR20 Escape Schedule, with the
probability

of maintaining a high rate of response in subsequent

sessions.
Following the establishment of the pre- i njection baseline band, the
injection

period proper was begun.

In this part of the procedure, the

subject was run on an FR20 for approximately 10 minutes warm-up (i.e.,
the initial)

prior to receiving a drug inj ection . The actual recorded

exper i mental session was init i ated by the intraperitoneal

injection

of

the drug . The recording sess i on lasted 50 mi nutes.
Inject i on procedures were based on the usual procedures (Thompson
and Schuster,

1968).

These included dosage calculations

based on

known LO 50 levels for gold thioglucose as reported by Wagner and
DeGroot (1963) for the rat .
Following the establ i shment of the baseline,

Rl2 was initially

injected with 0. 5 cc of sesame oil to screen for undesirable effects
from the vehicle .
following injections
drug injection
injection

The injection

series for Rl2 consisted of the

of gold suspended in sesame oil,

in which each

session was followed by at least one or more non-drug-

sessions,

thus allowing for recovery of the baseland band
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Subj ect Rl 2 on FR20escape schedule : responses per minute
follow i ng admi ni stration of gold, gold thiomalate, and gold
th i oglucose .
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response rate prior to injecting

once again:

10 mg, 10 mg, 25 mg,

25 mg, 50 mg, 50 mg, 75 mg, 75 mg, and 100 mg. The subiect was subsequently given a single 25-mg gold thiomalate injection.
recovery of the baseline,

a final 200-mg injection

Following

of gold thioglucose

was administered and escape behavior was followed for several additional
sessions .

At least one or more recording session followed each drug

administration,
the baseline .
appreciable

depending on whether the response rate departed from
The criterion

vehicle which was used consisted of no

deviation from the baseline band.

The technique of

allowing for recovery of the baseline after a drug injection
repeating the procedure was followed .

It is the intrasubject

tion technique (Sidman, 1960) which increases
confidence in the reliability

and then

of resulting

replica-

the experimenter's

data with few subjects.

Results
Calculations

were made daily following the termination of an

experimental session to determine the results
char ted so that deviations

of that session,

and

from the baseline could be made apparent.

Figures 1 and 2 represent the complete experiment for Rl2, as well as
an indication

of response rate deviations

from the initial

and body weights of the pre-drug administration

baseline

period.

It is apparent from the graphs that for all gold injections

through

session 27, rates of response were confined to the wide baseline band
(Figure 1).

The subject's

response rates increased significantly

above baseline levels following the last gold injection,
to over 100 responses per minute for several sessions.

increasing
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Rl2 was subsequently injected with a single gold thiomalate injection of 25 mg. In the subsequent two sessions,

response rates fell

from over 100 to 13 responses per minute, the lowest rate in the experiment and well below the baseline band.
levels (i.e.,
final injection

50-60) was noted in the subsequent three sessions.

A

of 200 mg of gold thioglucose was administered to Rl2.

Response rates fell
(i.e.,

Recovery to above baseline

to less than 30 responses per minute on two sessions

at the lowest rate within the baseline band) without achieving

recovery at the termination of the experiment .
The response rate drops following gold thiomalate and gold thioglucose administration

were quite significant,

per minute, qualitative

as at 15 or 20 responses

changes in behavior are evident.

Furthermore,

no recovery from the gold thioglucose was evident at the termination
of the experiment, indicating

the possibility

of permanent behavioral

changes, associated with extensive hypothalamic damage as a result

of

the heavy 200 mg dose of gold thioglucose .
As for weight fluctuations
a slight

(Figure 2), the general trend was toward

increase upward (i . e . , from 290 to 320 gm), although a tem-

porary large weight drop was observed following the 100 mg injection
gold, the 25 mg injection

of gold thiomalate,

of

and the 200 mg dose of

gold thioglucose .
Discussion of results
Until the gold injection
trend was quite misleading,

series

had been completed, the general

for in checking Figure 1, it was evident

that the baseline response rate was not altered
series;

i.e.,

by the gold injection

the response rates for most of the sessions fell

in the

middle of the baseline band at around 40-50 responses per minute.

In

42
the sessions following the 100 mg gold injection,

however, the average

daily response rate increased from an average of approximately 40 to
50 responses per minute to 100 or more responses per minute.
be determined by graphic inspection

in retrospect,

tion suppressed the response rate potential,

that gold administra-

as evidenced by release

of suppression in the sessions following discontinuance
administration,

of gold

in which response rates increased markedly, probably

associated with detoxification
The injection
injection

It can

processes.

of 25 mg of gold thiomalate which followed the gold

series was associated with a drop in response rate from an

average of over 100 responses per minute to a low rate of 13 responses
per minute.

This decrement was followed by a recovery of response

rate to the initial
malate injection.

baseline rate four days following this gold thioIt can be noted (Figure 1) that the decrease in

response rate did not follow the administration
during the drug injection

session,

of gold thiomalate

although 24 hours later a drop in

rate was quite evident .
The final

200 mg gold thioglucose in j ection did not affect

rate during the drug session,

response

although in the following sessions the

response rates fell to a low level .

Baseline recovery rate did not

occur prior to the termination of the experiment .
The temporary weight losses which were observed suggested that
there were toxic effects

due to the chemical compounds on either

hypo-

thalamic centers or other parameters of the animal's biochemistry.
A likely explanation for the apparent long-term suppression of
behavior following gold thioglucose administration

as opposed to the

temporary suppression noted with gold might be related

to the differential
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biological

distributions

deposition

is limited to abdominal organs.

gold deposition

of the two compounds.

is localized

In the case of gold,

With gold thioglucose,

the

abdominally (Block, Buchanan, and Frey-

berg, 1942), as well as hypothalamically

(Debons et al.,

1962).

44

EXPERIMENT
2
Gold thiomalate (Myochrisne) is a drug which has been routinely
used on humans and is, therefore,

equally important as gold thioglucose

from a medical point of view.
Method
Subjects
Three female rats (Long-Evans strain--R4,
in this experiment .

R5, and RlO) were used

They were three months old at the start

of the

sessions and were experimentally naive .
Apparatus
The same apparatus was utilized

as described in Experiment 1.

Procedures
The same procedures were utilized

as in Experiment 1 except for

changes in drug dosages .
R4 and R5 were given identical
follows:

vehicle injection,

possible desensitization

dosages.

Dosage schedule was as

gold thiomalate 10 mg, 25 mg next day (for

effects),

then 10 mg, 25 mg, and 50-mg dosages.

RlO, on the other hand, was injected twice with gold thiomalate 10-mg
dosages following the sesame oil control injection .
combined 10-25-mg dose for R4 and RS initially,

Except for the

all drug injections

were followed by recovery of baseline prior to reinjection.
Results
The initial

double dose of 10-25 mg of gold thiomalate was not
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followed by departure from the baseline in R4 or R5.

Consequently, a

second dose of 10 mg of gold thiomalate was administered to the two
subjects .

In the case of R5, death occurred within 48 hours, which was

preceded by a profound drop in rate on the last session .

Response

rates dropped extremely below the baseline band of 30-45 responses per
minute for the f i ve preceding sessions

(Figures 3 and 4).

was quite similar to that of R5's, but subsequently,
baseline rate occurred .

R4's record

recovery of the

R4 was next inj ected with a 25-mg dose of

gold thiomalate.

Baseline recovery took almost two weeks following this

25-mg injection .

A final 50-mg dose of gold thiomalate resulted

in a

decreased rate from which the animal failed to recover its baseline
activity

prior to termination of the experiment (Figures 5, 6, and 7).

In the case of RlO (the third thiomalate subject),
thiomalate injection

a single 10-mg gold

depressed rates of responding for nearly two weeks

before recovering the original

baseline rate.

A second 10-mg gold

thiomalate dose was in j ected into RlO with no apparent baseline recovery
at termination of the experiment (Figures 8 and 9).
As for weight flu ct uations,

the striking

similarity

in curves

for weight loss and response rate drops for all three gold thiomalate
subjects
ability

(i . e . , R4, R5, and RlO) indicates
that toxic abdomin al effects

contribute
injected

that there is a high prob-

from the gold thiomalate may

primarily to the response rate decrease in gold thiomalatesubjects .

Also, response rate decrememts are demonstrable

for weeks or longer following a gold thiomalate injection,
indicating

the long-term toxic effects .

by the larger dosages (e.g.,
pronounced toxic reactions

Finally,

50 mg) being tolerated
visible .

thus

tolerance is indicated
(e . g., R4) without
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Discussion of results
Because of the high solubility
thiomalate,

the investigator

and R5 with an initial
ing day.

ionic state of the gold

attempted to "desensitize"

10-mg dose followed by a 25-mg dose the follow-

point of view.

The data from Figures 3 through 7

that following combined gold thiomalate injections,

rate did not fall off on the following session (i.e.,
response rates for R4 and R5 were maintained).
additional

animals R4

This could be considered to be a prolonged 35-mg injection,

from a conservative
indicate

and partial

response

the baseline band

Consequently, an

10-mg dose followed for both R4 and R5. Within 48 hours,

R5 died, but R4 survived,
for both subjects.

although response rate dropped drastically

Consequently, a rough LD 50 (i . e . , lethal dose for

half the number of subjects)

could be put at about 35 mg, or 0.15 mg

per gram of body weight for gold thiomalate in mature Long-Evans female
rats .
Fast interresponse

times (IRT's) generally

with a rapid response rate,

indicating

corresponded (Figure 6)

that no great change had occurred

in non-responding while the shock treatment was on.

It can be noted

that from a mathematical point of view, should a reversal

occur for

fast IRT's (i . e . , high per cent of fast IRT's with a low response rate
per minute), then the conclusion reached would be that non-responding
is increasing

at a disproportionately

high rate (i.e . , if per cent of

fast responses is high while overall response rate is low, the few
slow responses must be very long).
As for weight changes, in the case of R4 the weight chart closely
parallels

the response-per-minute

the assumed index of toxicity

chart,

(i.e.,

indicating

a relation

between

weight loss) and the associated
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response behavior (i.e.,

drop in response rate).

The relation

should

not be considered as exact, since the operant response of eating is not
likely to be perfectly

related to the loss of the reinforcer's

strength from liver toxicity,

brain effects,

(food)

or other biological

concomitants .
It can be concluded from these data that injections

of gold thio-

malate are followed by a large drop in response rate as well as rapid
weight loss within 24 to 48 hours following administration,
eventual recovery of baseline may be noted .
had also received a gold thiomalate injection
with similar results.

A fourth subject (Rl2)
(25 mg) (see Experiment 1)

As gold thiomalate administrations

the tendency toward drug tolerance in rats can be inferred
data.

although

are repeated,
from the
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EXPERIMENT
3
Gold thioglucose
therapeutic

is not only important because it is a medical

agent in rheumatoid arthritis

(i.e.,

Solganol), but lesions

produced in the VMNof the mouse hypothalamus (Marshall, Barnett,

and

Mayer, 1955) have opened up a new avenue of behavioral and physiological research into obesity resulting

from overweight, overeating,

and

associated emotional changes.
Method
Subjects
Four three-month-old female Long-Evans rats (R7, R9, Rll, and R6)
served as the subjects for this experiment.

They were naive prior to

the experiment.
Apparatus
The apparatus used in this experiment was the same as for Experiments 1 and 2.
Procedures
Procedures were the same as in the previous experiments, except
for drug dosages, which were individualized--not
variability,

but also because of the different

rates.

(The subject of schedule effects

earlier

section.)

R9 was a rapid FR20 responder (i.e.,
responses per minute).

only because of subject
schedules and baseline

has been considered in an

baseline band of 80 to 100

R7 was a medium-rate responder on a fixed ratio
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of 20 (i.e . , from over 40 to over 50 responses per minute baseline band) .
Rll and R6 were on an FR12 Escape Schedule, both stabilized
low response rate (i.e.,

on a fairly

10-20 responses per minute for R6 and 20-30

responses per minute for Rll 's baseline level).

The drug dosages for

each subject are indicated

Figures 10 through 21).

in the graphs (i.e.,

A return to baseline activities
the sessions.

was attained

in the majority of

Higher dosages of the drugs were given when activity

was below the established

baselines

to study effects

dosages when baseline recovery was practically
attempting retraining

of increasing

unachievable without

procedures.

Results
After the establishment
the injection

of the high response rate baseline for R9,

series was initiated.

0. 5 cc of sesame oil,

Following the control injection

a combined 10-25-mg gold thioglucose

given to provide for desensitization

should sensitivity

profound drop in response rate occurred (i.e.,
60 responses per minute per session),
band for three sessions .
baseline.

of

dosage was

be involved.

A

down to approximately

which remained below the baseline

This was followed by a recovery of the initial

A second 10-mg dose was administered to R9, which also

brought the rate down to approximately 60 responses per minute (Figures
11 and 12) prior to once again attaining
followed by a series

of double 25-mg and 50-mg injections

drop below the baseline band.
was associated

This was
without any

The final 50-mg gold thioglucose

dose

with a drop in rate to 60 responses per minute, well

below the baseline band.
baseline,

the baseline .

After nine days without recovery of the

the subject was injected with 150 mg of gold thioglucose

study the effects

of a much heavier drug administration.

Following

to

57
~

E
0

.;,

~

E

0

.."'

LO

<,;

N

j

C',
0

:s

0

'C

u"

O J,
c.,E

.s::
...,

j

.Q

"O
·o

t

• (!)

"'
"'8

150

0

ill
0

...

:E

"

"O

0

8

0

"'

c.,

0

j

j

Cl

C)
0

:2

"O

0

0

·oa,

(!)

d,

E

11 0

E

g
j

0

Cl

"O

:2
...,

:E
... 0...

LO

12 0

.;,

:i * ..

C',

130

E

g

.?

140

.;,

E

!

0

(!)

!

0

"O

0

(!)

.;,

g

0

"
j

c:;

0

".,
iii
"'
'"'

..
a.

i

100

8
j

C)

.Q

90

.s::
....
"O

"'

0

j

C

.E

(!)

80

.,
""
a.

ic:;

70

0

lit
a,

a:

60

50
40

30

20

10

10

30

20

40

50

Sessions

Fi gure 10. Subject R9 on FR20escape schedule: responses per minute
following administration of gold thioglucose in increasing
dosages .

58

d,

E
.. E
od,

d,

E

51LO

0

ON

• <J,

G)

V

;:10

LO

c,u

'-' ~

a,

0

"'
0

0:,
o. ·~.s;."'

u
:l

O "OJ:

~r
a,Q ~

Ee.:,~
100

~

"'
£

:.-:;:+-" 0

8
:,

0

Cl
.Q

t1l c.::,

...,

.s;.

"O

0

c.::,

90
C:

0

"i
a,
.,,

80

b
Q)

a.
,.,,
....

· CC

-

\

\

''

70

'

':9
a.

~
60
..,.
C'.
a,

'-'

o;
"'

c..

50

40

30
10

30

20

40

50

Sessions

Figure 11,

Subject R9 on FR20escape schedule: per cent rapid IRT's
over sessions following administration of gold thioglucose
in increasing dosages,

59

.,;,
E

.,;,
.,;, E
E

300

0
0,

E

290

280
C:

"'
"'

270

iii

a.

"'
E

.,
"'

0
<J
:,

Lt) "'Lt)

0,

0

:c
...

. l3N
~Oc,u
::I!

0

(J"'

260

.,;, .,;,
E

"'0:,

0

E:Co,

5t
0
(J
:,

E

g g
"'
"'
0
:,
"'

C>
0

:c
...
'"O

0

Ol

(.!)

0

:g

'"O

31t-.2

0

'Bi

51

·Ot

8 ....

g

:!:'

i

'"O

"''"O.c:
(/) -+--'

fi~

C)

£
.c:
C)

...

·s::
., 250
240
230

220
10

30

20

40

50

Sess ions

Figure 12. Subject R9 on FR20escape schedule: weight fluctuations
over sessions following administration of gold thioglucose
in increasing dosages,

60

u

"
·o
L!l

ci

Cl>

E
fg

80

Jl!t
.
~ E
5! 0.-

0

70

" .,"'
:::,

0)
0

C:

0

·1

60

ill

8
:::,

8:::,

:c
Cl
.,., 0
"O :c
0 ..

a,
.Q

...

.c

"O

"O

0

t0.

0

(!)

(!)

20

10

10

30

20

40

50

Session s

Figure 13. Subj ect R7 on FR20escape schedule: responses per minute
follow i ng admi nistration of gold thioglucose.

61

en
E

...
rJ., E
0

100

U"'

Ll'lo
02 .,"'

- "'
·~
o
0 ,-

90 ;

0,

0

.,.c

0

'-'
~

C)

E'"' 0
ix:!2 :c

..

c,ic3

C:

0

'ill

5! 80

...
.,
a.

"' 70

~

a:

'a.
.,... 60
...
.,
"C

C:

...
.,
u

0.

50
40

30
10

30

20

40

Sessions

Figure 14.

1

Subject R7 on FR20escape schedule: per cent rapid IRT s
over sessions following administration of gold thioglucose.
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Subject Rll on FR12 escape schedule: per cent rapid IRT s
following administration of gold thioglucose in gradually
i ncreas i ng dosages .
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Subje ct Rll on FR12 escape schedule: weight fluctuations
follow in g administration of gold thioglucose in gradually
increa sing dosages.
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this injection,

response rates dropped much lower, resulting

complete deterioration

in almost

of the fixed ratio behavior, in contrast to the

high and stable response rates evident two weeks previously for R9.
Weight fluctuation

data for R9 is quite significant

correspondence with response rate data .

in its lack of

Although weight drops are

evident following some of the heavy gold thioglucose dosages, weight
recovery is quite complete within several sessions,

in contrast

absence of response rate recovery for the gold thioglucose.
example, following the 150 mg gold thioglucose administration,
rates dropped drastically
losses--although

to the

For
response

with no apparent recovery; while weight

falling

far below the baseline--were

recovered, result-

ing in the highest final weight recorded during the experiment for R9.
Following the vehicle injection

into R7 (Figures 13, 14, and 15),

a 10-mg dose of gold thioglucose was given the animal.
rate did not fall
session.

below the established

R71 s response

baseline based on the following

Consequently, a second 10-mg gold thioglucose injection

administered.
the original

The rate dropped as a result of the treatment.
baseline was not reestablished,

was

Since

after two weeks the

animal was injected with a 50-mg gold thioglucose dose to note behavioral
effects
levels.

superimposed upon an activity
No substantial

level below the baseline response

response rate changes in the direction

of base-

liQe recovery were noted prior to the death of the subject.
R6 (Figures 16, 17, and 18) received a vehicle injection,
gold thioglucose
finally

injection

that was followed by a 50-mg, 135-mg, and

a 300-mg gold thioglucose injection.

anaphylactic

a 10-mg

After this treatment,

reaction occurred and death ensued.

an

Wide fluctuations

in response rate were noted throughout the experiment with R6 (i.e.,

both
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increases

and decreases in rate following administration

almost totally

of the drug,

within its baseline band of 10-25 responses per minute).

For Rll (Figures 19, 20, and 21), which was on an FR12 escape
schedule and had a low rate of 10 to 25 responses per minute for its
baseline band, an inconsistent
limits,

response pattern,

within baseline

was recorded ,

For all four subjects,

weight fluctuations

were relatively

minor

(Figures 12, 15, 18, and 21), except for the large weight drop following
the 150-gm gold thioglucose

injection

into R9 and the 135-mg injection

into Rll ,
Discussion of results
In the case of R9, a rapid drop in response rate was demonstrated
following the first

10-25-mg gold thioglucose injection . There was a

subsequent recovery of baseline rates , A second phase of relative
stability

of response rates followed, and this was associated with a

number of increasing dosages of gold thioglucose administrations.
most likely explanation for the observed stability
of tolerance.
continuation

Subsequent deterioration
of addi tional injections

cumulative toxic effects

The

was the development

of response rate without a
points to the possibility

for

which overcame the organism's tolerance

capacity .
R7 s rapid deterioration
1

the

11

strained

intermediate

11

of response rate could be attributed

character of its response behavior--recognized

to

in the

baseline response rate of approximately 40 to 50 prior to

drug injection--and

to subsequent toxicity

noted in the observation of

tremors development following the 50-mg gold thioglucose injection.
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Subsequent lethal effects

point to the particular

sensitivity

of R7 to

gold thioglucose .
R6 and Rll had stabilized

at a low rate of response (i.e.,

responses per minute) with a relatively

short ratio (i.e.,

10-30

12), and

were not subsequently appreciably affected by gold thioglucose inject i ons.

This effect was probably due to both the ease of responding

at low rates on a short ratio,
the increasing dosages .

and possible tolerance development to

No decrease in response rate over several

sessions was noted in the case of Rll.
with Winogard s (1965) predictions;
1

Schedule effects

i.e.,

did correspond

greater stability

associated

with drug effects with subjects trained under short fixed ratios.
Furthermore, lack of pronounced weight fluctuations,
following very heavy dosages of gold thioglucose,

except

point to the rela-

tively less toxic nature of gold thioglucose in comparison with the
large weight fluctuations
The major differences

following gold thiomalate injections.
between gold thioglucose and gold thiomalate

were that weight losses were associated with the injection
malate following most drug administrations,
injections,

of gold thio-

but with gold thioglucose

only the heavier dosages affected body weight significantly.

Also, when both short and long fixed ratios were considered, as well
as response rates associated with the ratios
evident that gold thiomalate injections
in response .

in all subjects,

were always followed by decrease

In the case of gold thioglucose,

rate decrements generally

accompanied only the heavier dosages and then only in strained
conditions.

it is

For example, Rll, on a low-rate FR12 ratio,

ratio

was not

appreciably affected by the 300-mg gold thioglucose dose; while in the
case of the strained character of R7 s response record--an intermediate
1

72

response rate subject--gold
followed by a definite

thioglucose drug administrations

downwardtrend in response rates.

were

73

EXPERIMENT
4
In 1960, Mayer stated that although rats can be injected with heavy
gold thioglucose dosages compared to mice (i . e . , 1 mg per gram of body
weight), and hypothalamic lesions consequently form, the rat does not
survive the toxicity

and consequently cannot become obese as is the

case in approximately 50 per cent of injected mice.
Method
Subjects
Six rats served as subjects for this ethological
male Long-Evans rats,

over three months of age.

study.

Three were

The other three subjects

were female Long-Evans rats which had been run on escape schedule
procedures and administered gold thioglucose injections

prior to the

final part of the study.
Equipment
In this investigation,
syringes .

injections

required the utilization

of

Weighing was by means of a balance, accurate to the nearest

0.1 gram.
Procedures
The three male rats were injected with 1.0 mg per gram of body
weight of gold thioglucose.
as follows:

Rl, the fourth subject (female), was injected

10 mg on a morning session, 50 mg 48 hours later,

96 hours later,

and 300 mg 96 hours later ,

145 mg

Three hundred mg corresponded

to over 1.0 mg per gram of body weight for Rl.

(See Figures 22 and 23.)
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R6 (female) was injected
between drug injection

in the same dose and interval
series.

Rll, the sixth subject,

graduated gold thioglucose injections,
dosages:

(i.e.,

as Rl)

was injected

in

which included the following

10 mg, 25 mg, 50 mg, 135 mg, and 300 mg.

Results
The three male rat subjects were dead in their cages on the following morning.
finding;

This phase of the experiment replicated

i.e.,

gold thioglucose

Mayer s (1960)
1

that a single l mg per gram of body weight injection
is fatal

of

to rats.

Rl 1 s progress can be seen in Figure 22.

The subject survived the

very heavy dose of 1.0 mg per gram of body weight, thus providing the
basis for rat hyperphagia and consequent obesity (Mayer, 1960).
the first
for Rl.

10 days after treatment,

obesity .

no large weight increases were noted

A weight reduction was noted on the first

300-mg injection,

day following the

but recovery was complete in several days, with no

Following experimental session resumption, response rates

increased above the baseline levels

(Figure 22).

R6 died within two minutes after the 300-mg injection,
indicative

Within

of an anaphylactic reaction .

with symptoms

Rll survived the initial

300-mg

dose and completed the requirements of the FR12 escape schedule for
that day (i . e., 50 minutes of operant responding).
the 300-mg injection

It also survived

and maintained its operant behavior on the following

days, prior to the termination of the experiment.
Discussion of results
In relation

to the massive final gold thioglucose injection,

cations of drug toxicity

based on weight loss were minimal.

indi-

Rl and Rll
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survived the 300-mg dosage of gold thioglucose.

By developing tolerance

to the drug, it would appear that much heavier dosages of gold thioglucose can be injected

into a rat .

It is possible that since the data for Rl and Rll establish

a

precedent for a probable increase in the tolerance for gold thioglucose
in rats,

increases in the size of the hypothalamic lesions,

as behavioral changes, may be expected in rats.

as well

With these dosages,

similar lesions and behavioral changes may occur in higher species.
Rl, which initially
relatively

failed to respond to shock, responded at a

high rate following the 300-mg gold thioglucose injection,

possibly due to neurological

alterations

which affected the behavioral

sets (Figure 22), thus allowing for greater

flexibility

possibly associated with changes in drive states.

of response,

78

ADDITIONAL
OBSERVATIONS
Gold Thioglucose and the
Anaphylactic Response
A most interesting

phenomenonthat impinges on physiology and

behavior both is the anaphylactic reaction--sometimes

fatal--and

lesser reactions which seemingly stem from the same cause.
Stein, and Park (1964) investigated

the possibility

the

Luparello,

that following

hypothalamic damage (and, consequently, likely autonomic malfunctioning),

a decrease in anaphylact i c reactions might result in hypo-

thalamically-damaged rats .

Positive results were obtained .
Method

Subjects
Two rats of the Long-Evans stra i n served as the subjects .
control subject was a normal non-in j ected animal.
subject,

The

The experimental

Rl3, was a rat which had been i nj ected with 40 mg, 70 mg, and

100-mg dosages of gold thioglucose within a 72-hour period approximately
four months prior to the exper i ment.
Materials
The sensitizing

drug for the experiment was sodium levothyroxine.

Egg white was the protein made available for injections .
Procedures
Although the problem of developing an anaphylactic reaction in the
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rat is fraught with difficulties,
resistant

particularly

as rats are quite

to anaphylactic shock (Sanyal and West, 1958), the method of

sensitization

found successful

subjects were first

by Leger (1947) was attempted.

injected with 0.15 cc of egg white.

The two

During the

following 12 days, the two subjects were tube-fed the 100 gammaof
sodium levothyroxine and were otherwise on free feed.
12-day sensitization

At the end of the

phase, each subject was injected with 0.3 cc of

egg white.
Results
No immediate reactions were noted.

Within 90 minutes, the feet,

as well as the area surrounding the mouth, of the normal rat swelled
extensively.

In the case of the experimental rat,

no such swelling

appeared to occur .
Discussion of results
Although the investigator

considered the total procedure to be

of an exploratory nature, rather than quite reliable,

the swelling

noted with the normal rat and absent in the gold thioglucose-injected
rat points to the possibility

that hypothalamic-lesioned

tissue of

the experimental animal may have been causally related to the supporting
mechanisms for anaphylactic reactions .
replication
neurological

The possibility

of a successful

of such phenomenawould lead to a technique of studying
contributions

to allergic

conditions.

Balance BeamApparatus
Nineteen categories

describing rat behavior were arbitrarily

developed prior to the initiation

of the experiment.

In the sessions
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prior to the establishment of a relat i vely stable baseline,
noted that some of the proposed categories
observed behavioral traits.
initially

F~rthermore,

it was

di d not correspond to the
a gradual reduction in the

observed behavior was evident in later sessions that preceded

drug administration .
The subj ects were the same rats run on the escape operant procedures, including Rl, R6, R7, and R9 with gold thioglucose;
and R5 on gold thiomalate injections;
gold thioglucose,

R4, RlO,

and Rl2 on all three (i . e., gold,

and gold thiomalate) .

Subjects were repeatedly placed on the beams for a total

count of

five times (Figure 24), after which they were observed for the balance
of the allotted

three minutes.

All observat i ons were recorded daily on

the mimeographed sheets (see Appendix), i ncluding weight of the subject
whi ch was obta i ned by wei ghi ng each ani mal prior to placements on the
beam apparatus .

Indi vi dual obser vat i ons of each subject were made

dai ly by th i s procedure .

Walled enclosu r e

Figure 24.

Balance beam apparatus.

Placement beam
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Data were subjected to a statistical
frequencies

(see Appendix Table 1).

analysis,

utilizing

per cent

Baseline behavioral activities

in

per cent of occurrence (based on the last 10 days prior to initiating
drug injections)
following .

were compared with post-baseline

drug-injected

sessions

In this study, subjects served as their own controls.

A statistical

analysis of the data indicates

that mobility on the

high beam (see Appendix, number 5), return to beams (number 12), and
climbing on beam apparatus enclosure (number 19) distinguished
behavior from drug sessions.

baseline

Activ i ties of the above categories

decreased for most of the subjects.

Also the time for remaining on

beam (number 18) following placements on the beam was a useful criterion,
as time on the beam increased following drug administrations.
The most likely explanation for the above results
motor activity,

is that difficult

such as is represented in numbers 5, 12, and 19, is

reduced in frequency following abdominal and possibly neurological
alterations
18).

in subj ects,

as well as overall reduction in movement (number

As for weight fluctuat i ons throughout the several experiments

(see Appendix Table 1), eight of the nine subjects gained only 5. 5 gm
from age three months at the initiation
drug and post-drug injection

of the experiment, through the

experimental sessions.

In the case of the gold, gold thioglucose,
subjects,

and gold thiomalate

the heavy i nj ections were often associated with a temporary

weight drop, followed by slightly
sequent sessions

increasing weight gains in the sub-

(Figures 2, 7, 9, and 12).

The biological

effects

which had been demonstrated to be associated with the administration
of the above compounds are kidney damage and liver damage (i.e.,

abdominal
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organ damage) (Block, Buchanan, and Freyberg, 1942), as well as ventromedial hypothalamic lesions for gold thioglucose

(Wagner and DeGroot,

1963).
In connection with weight changes, the above weight fluctuations
noted correspond to Cox, Kakolewski, and Valenstein's

(1969) control

group weight, rather than the experimental group which had been
stereotaxically

lesioned in the ventro-medial hypothalamus.

apparently insignificant
gold thioglucose-injected

The

long-term weight changes in the case of the
subjects at Utah State University argues for

an hypothesis that abdominal damage associated with anorexia and
hypophagia counters or compounds the characteristic

hyperphagia and

obesity which accompanies ventro-medial hypothalamic damage; and such
damage is assumed to have occurred in all or most of the Utah State
University subjects injected with 0.5 mg per gram of body weight or more
of gold thioglucose

(Wagner and DeGroot, 1963).

Because of the likelihood

of extensive damage at both the abdom-

inal as well as the hypothalamic levels,

hyperphagia and obesity would

probably not be observed due to antagonistic
although other behavioral effects
lesions could be expected.

cancelling effects,

associated with extensive hypothalamic
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OBSERVATIONS
ONTHEEFFECTS
OF GOLDCHLORIDE
Gold chloride has long been known to be a toxic drug (Drill,
and is consequently no longer utilized
interest

in medical practice.

1954),

The

in the drug from a behavioral pharmacological point of view

stems from the fact that the gold moiety of the compoundis highly
ionic,

providing it with the potentiality

tissue.

of rapidly destroying

Studies of a pharmacological nature concerning its action

have consequently not been carried out in decades.
high toxicity
involvements.

Its hypothesized

had led to the ignoring of the possibility
Being of no potential

behavioral research,

of CNS

importance in medicine or

the drug effect was not studied with the more

precise operant procedures.

It was felt that gross observations would

suffice.
Method
Subjects
Two female rats,

one of the Long-Evans strain

and the other

Albino, served as the subjects , The subjects were experimentally
naive and were three months of age .
Equipment
Aqueous gold chloride and syringes were available

in the laboratory

for injection.
Procedures
Because of the attributed

toxicity

of the drug, the following two
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dosages were administered:

20 mg on the first

session;

skip several

days, 50 mg on the second session.
Res~lts
In the case of the Albino rat,

following the injection

gold chlor i de dose no noticeable effects
second dose of 50 mg was administered .
following morning.

were noted.

of a 20-mg

In 48 hours, a

S was dead in its cage on the

Autopsy performed by the investigator

revealed

that no clumping or ot her signs of gold could be found at the site of
injection

(intraperitoneally).

The Long-Evans subject was also injected with a 20-mg injection
of gold chloride initially.
citating

Effects were extremely profound, incapa-

the subject so that it was unable to walk by the second

post-injection

date .

Death followed soon afterwards,

and consequently

a higher dosage was not required .
Discussion of results
Gold chloride i s evidently the most toxic of the gold compounds
whi ch have been consi dered .
within the GI tract,
i ncapicitation
biological

It appears to be completely absorbed

as none was evident intraperitoneally.

From the

of the Long-Evans subj ect prior to death, massive

damage could be assumed, although CNStissue damage could

not be ruled out from the evi dence noted .
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DISCUSSION
Rl2 received gold, gold thiomalate,

and gold thioglucose injections

in Experiment 1, providing a meaningful intrasubject
all effects

comparison, since

occurred in the same animal, with its own unique behavioral

characteristics.
That the colloidal
was inferred

gold suppressed response rate of the subject

from the rapid increase in response rate that surpassed

and doubled that of the original
of colloidal

baseline level following discontinuance

gold administration.

In the experiments which were performed, gold thiomalate was
associated with response rate decrement and pronounced downwardtrends
in recorded weights of treated subjects.
Following graduated gold thioglucose administrations,
was evidenced from the relatively
with increasing

tolerance

stable daily response rates,

dosages and the relatively

even

minor weight changes

observed in the subjects .
In all four gold thiomalate subjects,
between toxic effects--assumed

for example, a correspondence

from loss of weight--and response rate

drop was noted . This relationship

was particularly

evident in R4's

record.
In Experiment 3 (i.e.,
the drug injected .
lesser toxicity

R9, R7, R6, and Rll), gold thioglucose was

Weight changes were minor, probably due to the

of the compound.

Tolerance of heavier gold thioglucose dosages was noted in R91 s
chart, where the 25 through 50-mg injec tio ns did not affect the
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baseline activity

during a number of sessions to any appreciable

degree .
The second experiment, utilizing
the effects

R4, R5, and RlO, demonstrated

of baseline rate for short and long fixed ratios

FR12 and FR20) with associated gold thiomalate injections.
was rapidly disrupted by higher dosages (i.e.,
case of gold thiomalate),
ratios.

(i . e.,
Behavior

10 mg to 25 mg, in the

and recovery was very slow on strained

Relearning might definitely

fixed

be a factor in recovery from gold

thioglucose and gold thiomalate effects

in view of the many sessions

required for recovery of such baselines.
A final 50-mg dose of gold thioglucose proved to be fatal to R7,
indicating

that the rat could not tolerate

The data suggest the possibility

large doses of the drug.

that injection

the maintenance of a tolerance state.

spacing might affect

An interval

spacing of greater

than three to four days (e . g., 12 days in the case of R7) might no
longer sustain the same tolerance levels in the subject upon subsequent injections.
R6 and Rll, responding to low ratios

(i.e.,

FR12) and intermediate

response rates (i . e., 25-35 responses per minute), were not demonstrably
affected by gold thioglucose
in response rate).

(i . e., either steady increase or decrease

The data point to the importance of the schedule

ratio and learned response rate for maintaining baseline behavior.
The explanation would probably be that when behavioral response requirements are minimal, or nearly so, the animal can continue responding
at a similar rate in spite of toxic drug effects.
An observation that was made in the case of Rll 's record was that
in spite of injections

of gold thioglucose up to a final dosage level
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of 300 mg (double that required for demonstrable hypothalamic lesions
(Wagner and DeGroot, 1963)), no significant

daily response rate changes

were noted on the graph . This demonstrates that response rates on
short ratios may be maintained following the administration

of the

highest gold thioglucose dose of 300 mg.
Ethological studies on Rl were preceded and followed by escape
schedule sessions .

The subject was not run the week following the

massive gold thioglucose
initial

toxic effects .

injection

to allow for recovery from the

WhenRl was subsequently run on escape, the

long periods of non-responding which were observed early in training
were no longer evident,

although no adequate explanation could be

given.
In all studies with gold thioglucose

(Wagner and DeGroot, 1963;

Mayer, 1960; Debons et al . , 1962) that utilized

several species,

the

hypothalamic damage which occurred could be assumed to be of comparable
magnitude to that following stereotaxic
Since following stereotaxic

lesions,

lesioning of the hypothalamus.

anaphylactic shock has been

demonstrated to be reduced in i ntensity

or elimi nated (Luparello,

Stein, and Park, 1964), the same possibility

for chemically-induced

lesions was assumed in this investigat i on.

The supporting evidence

from a single observation made on the one control and one experimental
subject was positive .
are difficult

Since anaphylactic reactions

to differentiate,

additional

of a minor sort

studies and replications

would be advisable.
The balance beam apparatus generally indicates
a behavioral baseline,

only a few of the initial

the rat subjects were retained.

Injections

that in establishing

responses emitted by

of gold compounds lead to
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the reduction of difficult
the beam enclosure--a

motor responses;

frequently-emitted

baseline prior to the drug injections .
the beam apparatus profitably
since with stimulating

particularly,

mounting of

response in establishing
The possibility

with stimulating

the

of utilizing

drugs was entertained,

drugs an expansi on of baseline activities

could

be hypothesized.
Gold chloride was considered worthwhile to study, although it was
known to be highly toxic (Drill,
decades ago.

The justification

1954) from studies conducted several
for replication

of its effects

is that

it is a gold compound, its gold being highly ionic (Orestano, 1932),
which is the assumed characteristic

responsible

A single gold chloride iniection
days, while two injections

for its toxicity.

of 20 mg killed R2 within two

(25 mg and 50 mg) killed the Albino subject,

lending support to the hypothesis that ionic reactivity
with toxic effects
coordination

of gold.

The lesser

combining with neurological

teristic
(Drill,

ionic characteristic

of the

complex compounds, gold thioglucose and gold thiomalate,

could well account for their effects,
(i.e.,

is associated

including brain reactivity

tissue) .

The greater ionic charac-

of the gold thiomalate compared with that of gold thioglucose
1954) would probably account for its greater toxicity

when these

two similar chelating compoundsare compared.
The answer to the problem stated earlier
gold compoundswould have the same effects

could probably be that

in humans as they have in

the mouse if comparable doses were administered .
the fact that gold penetration
species.

of brain tissue has been noted in several

Such a procedure is inconceivable

damage potential.

This is based on

in humans because of its

These comparable dosages could be achieved in man
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through the development of tolerance

induced by gradual dosage in-

creases as demonstrated in this study .
With the gold thioglucose injections
humans, lesions are unlikely,

administered routinely to

although gold deposition in the brain

could probably be demonstrated from a spectroscopic

analysis.

As for the hypotheses described below based on the experimental
data, most were confirmed.
Hypothesis

1:

Colloidal gold suppressed behavior.

was toxic to the animal and killed it easily.

Gold chloride

Gold thioglucose and

gold thiomalate neither killed all the animals (as would have been the
case with gold chloride),

nor were they limited to suppressing behavior

(as was the case with gold).

Instead,

they profoundly influenced

rates of responding within a day or two after injection .

Behavior was

often disrupted for a week or two pr i or to recovery.
Hypothesis

2:

Gold thiomalate as well as gold thioglucose were

associated with response rate decrements, particularly
ratios

on the longer

(i . e., FR20). A more pronounced and more reliable

associated with the admi nistrat i on of gold th i omalate.

drop was
Associated

weight losses generally followed the gold thiomalate administration.
Although gold thiomalate and gold thioglucose have abdominal
distributions

similar to collo i dal gold (Block, Buchanan, and Frey-

berg, 1942), their brain distributions
disruptive

effects

probably would account for

on behavior, where gold seems to only suppress

behavior (conclusion from Rl2 data).
Hypothesis

3:

Gold chloride proved to be highly toxic to rats,

probably due to its ionic character,
1932).

as previously postulated

(Orestano,
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Hypothesis

4:

Colloidal gold, although chemically inert,

affect the subject's
Hypothesis

5:

did

behavior; it also suppressed response rate.
Gold thiog l ucose--assuming that the subject was

hypothalamically -lesioned--poss i bly mi ght have prevented anaphylaxis.
No generalized

conclusion can be made concerning the anaphylactic

reaction on the basis of the l i mi ted evi dence gathered.
Hypothes i s 6:

Gold th i omal ate was more toxic and disruptive

response rate than gold thioglucose,

of

and loss of weight was much more

profound following the in j ections of gold thiomalate when compared
with gold thioglucose.

This differen ce could be attributed

to the

greater ionic character of the th i omalate compound.
Hypothesis

indicated

7:

Since the work of Denko and Anderson (1944) had

that tolerance and cross-tolerance

between gold compounds

occur in an organism, it would be expected to be expressed behaviorally.

Following the gradual i ncr ease of gold thioglucose dosages,

tolerance was noted behaviorall y i n constant rates from session to
session in one subject (R9). Ani mals sur vi ved heavy dosages of gold
thioglucose

and response rates were with i n baseline limits once bio-

logical tolerance had been developed i n several rats.
Hypothes i s 8:

Although large hypothalamic lesions were probably

associated with a heavy concentr ation of gold thioglucose administration, hyperphagia and obesi ty di d not follow, probably due to anorexia
and hypophagia associated with l i ver and kidney damage, confounding or
countering the hyperphagia result i ng f r om gold thioglucose-induced
hypothalamic lesions .
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CONCLUSIONS
ANDRECOMMENDATIONS
Conclusions
1.

Gold (colloidal)

schedule.

suppresses response rates on an operant escape

Termination of drug administration

leads to an almost

immediate increase of response .
2.

Gold thiomalate and gold thioglucose decrease response rates

significantly
initial

with subjects on escape schedules following a fairly

dose (i.e.,

25 mg for gold thiomalate

for gold thioglucose).

large

and approximately 50 mg

The decrease occurred more regularly

in the

Gold thiomalate is more toxic than gold thioglucose,

being

case of gold thiomalate.
3.

associated with a much greater drop in response rate on an operant
schedule following an equivalent dosage to gold thioglucose,

as well

as a temporary loss of weight in the subject .
4.
rats,

Graduated dosages lead to tolerance of gold thioglucose in

so that a formerly considered lethal dose of 1 mg per gram of body

weight can be tolerated by the subject ,
5. Replication studies with gold chloride confirmed its highly
toxic and lethal effects
(i.e.,

on rat subjects at relatively

low dosages

25-50 mg).

Recommendationsfor Medical Therapy
with Gold Compounds
1.

Results from these studies indicate

gold compounds for rheumatoid arthritis

that should treatment with

be indicated,

gold thioglucose
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is favored over gold thiomalate because of the apparent greater inferred
toxicity
2.

of gold
thiomalate indicated by the experimental data.
t
A change of scheduling of dosages from the conventional method

of an initial

10 mg at intervals

to a total

of 750 mg (Remington,

1965) to much lower dosages in order to establish

and maintain toler-

ance with fewer undesirable effects ,
3.

Since clinical

(Patterson

evidence, including EEGstudies on humans

and Dale, 1966), indicate

istration

brain effects

following the admin-

of gold thiomalate and gold thioglucose,

spectroscopic

histological

brain examinations on deceased patients

and

who had been on

the drugs is recommended. This would probably lead to the removal of
the gold compoundsfrom therapeutic

utilization.

Behavioral Recommendations
1.

Further anaphylactic reaction studies on the effects

thioglucose

administration

on allergic

reactions

of gold

in animals should be

undertaken.
2.

Studies on the development of tolerance

to gold thioglucose in

cats, monkeys, and dogs should be undertaken so that the massive dosages
required for producing extensive hypothalamic lesions may be achieved.
This would allow for the analysis of brain damage-associated behavioral
changes utilizing

a chemical lesioning technique ,
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Three-Minute Observations Following Placements
of a Subject on the High Beam
of the Apparatus

Sub.iec;ts
#1 #2
1.

2.
3.
4.
5.
6.
7.
8.
9.
10.
11.

12.
13.
14.

15.
16.
17.
18.
19.

Weight prior
to placements
Passively falls
off high beam
Resists but falls
off high beam
Stationary on
high beam
Mobile on
high beam
Rearing on
high beam
High and low
beam mobility
High-low-high
beam mobility
Floor
mobi1i ty
Stationary on
floor
Floor
rearing
Return to
beams
Beam/floor ratio
high or 1ow
Twisting or
rolling on
floor
(ipsilateral)
Turning head
on floor
(contralateral)
Flip-fl ops on
floor
Numberof
boluses
Time on beams
fo 11owing five
placements
Jumping on top of
large enclosure

#3

#4

#5

#6 #7

I

I

I

#8 #9 #10 #11 #12

Table 1.

100
Frequency percentages of observed behavior over pre- and postdrug sessions

Number

Rl

1
2
3
4

5
6

B
A
B
A
B
A
B
A
B
A
B

A

8

17

A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A

18

B
A

19

B
A

10
11
12
13
14
15
16

R5

Ba 239 257 231
Aa 289 258 232

7

9

R4

B

0
33
0
0
81
100
92
0
36
0
0
0
0
0
0
0
0
0
0
0
0
0
100
94
0
0
0

0
0
0
9
6
180
170

0
0
0
0
0
0
9b
0
0
0
0
0
0
0
0
0
0
100 100
100 100
0
0
0 20
100 100
100 80
lOOb 36
0 20
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
0
0
0
0
36
0
0
0
0

6 5.3
13 5.2

0 100 100
0 41 60

R6

R7

R9

Rl0

Rl 1

Weight in grams
272 282.8 256 258.9 256. 1
274 297.9 263 266.0 256.8
Percent
0 100
0
0
20
12
0 100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0 20
10
0
80
0
0
0
67
0
0
0
80
0
0
62
0
0
0
0
0
0
0
0
10
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
100 100
100 100
90
92 100
84
93 100
0
0
0
0
0
0
0
0
0
0
100 100
100 100
100
93 97
84 100
87
0
0
30 40
1ob
0
0
8
0
0
0
0
0
0
80
92
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
0
49
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
70
0
0
0
0
Time on beam
5. 1
6
5. 3 5. 1
100
113
5.7 11.9
5. 1 9.7
Percent
100
71 40
90 80
24
36
17
83
0

R12

Combined
group
percent

292.5
302.0
0
0
0
0
0
0
30
0
0
0
0
0
,ob
0
100
100
0
0
100
100
60
5
0

31
11

(#5)

31
4

( #12)

0

0
0
0
0
0
0
0
0
6.8
17.5
70
11

35. 5
39. 1 ( #18)
72
30

as= Before drug treatments (baseline); A= After drug treatments.
bFrequency = Significance cannot be determined.

(#19)
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